skip navigation links
National Cancer Institute
Enterprise Vocabulary Services
Box
NCIm Version: 201808 (Browser Version 2.9, using LexEVS 6.5.1)
SearchBox Top
SearchBox Bottom
Blood Coagulation Disorders (CUI C0005779) Suggest changes to this concept
Add to Cart

Table of Contents

Terms & Properties

Concept Unique Identifier (CUI): C0005779

NCI Thesaurus Code: C2902  (see NCI Thesaurus info)

Semantic Type: Disease or Syndrome

NCIt Definition: A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.

HPO Definition: An abnormality of the coagulation cascade, which is comprised of the contact activation pathway (also known as the intrinsic pathway) and the tissue factor pathway (also known as the extrinsic pathway) as well as cofactors and regulators. [HPO:probinson]

NICHD Definition: A condition of abnormal blood clotting or bleeding.

SNOMEDCT_US Definition: Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system

CSP Definition: condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.

MSH Definition: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.

Synonyms & Abbreviations: (see Synonym Details)
Abnormality of the coagulation cascade
Blood clotting disorder
BLOOD COAG DIS
BLOOD COAGULATION DEFECT
Blood coagulation disorder (disorder)
Blood Coagulation Disorders [Disease/Finding]
Blood Coagulation Disorders
blood coagulation disorder
Clotting disorders
clotting disorder
CLOTTING
COAG DIS BLOOD
Coagulation abnormal
Coagulation defect, unspecified
Coagulation defects
COAGULATION DEFECT
COAGULATION DISORDER (NOS)
Coagulation disorder NOS
Coagulation Disorder, Blood
Coagulation Disorders, Blood
Coagulation Disorders
COAGULATION DISORDER
Coagulopathies
coagulopathy
DEFECT COAGULATION (NOS)
Defective coagulation NOS
DIS BLOOD COAG
DISORDER COAGULATION
Disorder of haemostasis
Disorder of haemostatic system
Disorder of hemostasis
Disorder of hemostatic system (disorder)
Disorder of hemostatic system
Disorder, Blood Coagulation
Disorder, coagulation
Disorder, hemostasis
Disorders, Blood Coagulation

External Source Codes: 
NCI Thesaurus Code C2902 (see NCI Thesaurus info)

Other Properties: Property Definitions
Name Value Source
ACTIVE 1 SNOMEDCT_US
AN GEN: prefer specifics; consider also COAGULATION PROTEIN DISORDERS and indentions; see also THROMBOSIS; EMBOLISM and specifics in C14; /genet: consider also BLOOD COAGULATION DISORDERS, INHERITED; DF: BLOOD COAG DIS MSH
AQL BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI MSH
CASE_SIGNIFICANCE_ID 900000000000448009 SNOMEDCT_US
Contributing_Source FDA NCI
Contributing_Source MedDRA NCI
Contributing_Source NICHD NCI
CTV3ID D30.. SNOMEDCT_US
CTV3ID XUPhW SNOMEDCT_US
DC 1 MSH
DEFINITION_STATUS_ID 900000000000074008 SNOMEDCT_US
DID 0438-1873 CSP
DX 19660101 MSH
EFFECTIVE_TIME 20020731 SNOMEDCT_US
EFFECTIVE_TIME 20090131 SNOMEDCT_US
FDA_Table Patient Code (Appendix B) NCI
IAN DEFAULT ICD10
MDA 19990101 MSH
MESH_DEFINITION Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. NDFRT
MESH_DUI D001778 NDFRT
MESH_NAME Blood Coagulation Disorders NDFRT
MESH_UI M0002683 NDFRT
MMR 20040719 MSH
MN C15.378.100 MSH
NDFRT_KIND DISEASE_KIND NDFRT
NICHD_Hierarchy_Term Coagulation Disorder NCI
NUI N0000000575 NDFRT
ORDER_NO 03471 ICD10CM
PRIMARY_PATH 10009802$10053567$10064477$10005329$Coagulopathy$Coagulopathies$Coagulopathies and bleeding diatheses (excl thrombocytopenic)$Blood and lymphatic system disorders MDR
PRIMARY_SOC 10005329 MDR
PT_IN_VERSION 10.0 MDR
PT_IN_VERSION 10.1 MDR
PT_IN_VERSION 11.0 MDR
PT_IN_VERSION 11.1 MDR
PT_IN_VERSION 12.0 MDR
PT_IN_VERSION 12.1 MDR
PT_IN_VERSION 13.0 MDR
PT_IN_VERSION 13.1 MDR
PT_IN_VERSION 14.0 MDR
PT_IN_VERSION 14.1 MDR
PT_IN_VERSION 15.0 MDR
PT_IN_VERSION 15.1 MDR
PT_IN_VERSION 16.0 MDR
PT_IN_VERSION 16.1 MDR
PT_IN_VERSION 17.0 MDR
PT_IN_VERSION 17.1 MDR
PT_IN_VERSION 18.0 MDR
PT_IN_VERSION 18.1 MDR
PT_IN_VERSION 19.0 MDR
PT_IN_VERSION 19.1 MDR
PT_IN_VERSION 20.0 MDR
PT_IN_VERSION 20.1 MDR
PT_IN_VERSION 8.0 MDR
PT_IN_VERSION 8.1 MDR
PT_IN_VERSION 9.0 MDR
PT_IN_VERSION 9.1 MDR
RXAUI 3118099 RXNORM
RXAUI 3118100 RXNORM
RXAUI 3134059 RXNORM
RXAUI 3148591 RXNORM
RXCUI 1022276 RXNORM
SID HP:0001925 HPO
SMQ_TERM_ADDVERSION 20.1 MDR
SMQ_TERM_CAT A MDR
SMQ_TERM_LEVEL 4 MDR
SMQ_TERM_LEVEL 5 MDR
SMQ_TERM_LMVERSION 20.1 MDR
SMQ_TERM_SCOPE 1 MDR
SMQ_TERM_STATUS A MDR
SMQ_TERM_WEIGHT 0 MDR
SNOMED_CID 362970003 NDFRT
SNOMED_CID 64779008 NDFRT
SUBSET_MEMBER 447562003~CORRELATIONID~447561005 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPADVICE~ALWAYS D68.9 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPCATEGORYID~447637006 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPGROUP~1 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPPRIORITY~1 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPRULE~TRUE SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPTARGET~D68.9 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~CORRELATIONID~447561005 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPADVICE~ALWAYS D68.9 | DESCENDANTS NOT EXHAUSTIVELY MAPPED SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPADVICE~IF AGE AT ONSET OF CLINICAL FINDING BEFORE 29.0 DAYS CHOOSE P61.6 | DESCENDANTS NOT EXHAUSTIVELY MAPPED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPCATEGORYID~447637006 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPCATEGORYID~447639009 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPGROUP~1 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPPRIORITY~1 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPPRIORITY~2 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPRULE~IFA 445518008 | Age at onset of clinical finding (observable entity) | < 29.0 days SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPRULE~OTHERWISE TRUE SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPRULE~TRUE SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPTARGET~D68.9 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPTARGET~P61.6 SNOMEDCT_US
SUBSET_MEMBER 900000000000497000~MAPTARGET~D30.. SNOMEDCT_US
SUBSET_MEMBER 900000000000497000~MAPTARGET~XUPhW SNOMEDCT_US
SUBSET_MEMBER 900000000000508004~ACCEPTABILITYID~900000000000548007 SNOMEDCT_US
SUBSET_MEMBER 900000000000508004~ACCEPTABILITYID~900000000000549004 SNOMEDCT_US
SUBSET_MEMBER 900000000000509007~ACCEPTABILITYID~900000000000548007 SNOMEDCT_US
SUBSET_MEMBER 900000000000509007~ACCEPTABILITYID~900000000000549004 SNOMEDCT_US
TERMUI T005165 MSH
TERMUI T005166 MSH
TERMUI T005167 MSH
TH NLM (1966) MSH
TH NLM (1992) MSH
TYPE_ID 900000000000003001 SNOMEDCT_US
TYPE_ID 900000000000013009 SNOMEDCT_US

Additional Concept Data:  (none)

URL to Bookmark: https://ncim-stage.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&code=C0005779
Synonym Details:
Term Source Source List Type Term Type Definitions Code
Abnormality of the coagulation cascade
HPO PT HP:0003256
Blood clotting disorder
SNOMEDCT_US SY 64779008   View In SNOMEDCT_US Hierarchy
BLOOD COAG DIS
MSH DEV D001778
BLOOD COAGULATION DEFECT
DXP FI U000386
blood coagulation disorder
AOD DE 0000005928
blood coagulation disorder
CSP PT 0438-1873
BLOOD COAGULATION DISORDER
DXP SY NOCODE
Blood coagulation disorder
HPO ET HP:0001928
Blood Coagulation Disorder
MSH PM D001778
Blood coagulation disorder
SNOMEDCT_US PT 64779008   View In SNOMEDCT_US Hierarchy
Blood coagulation disorder (disorder)
SNOMEDCT_US FN 64779008   View In SNOMEDCT_US Hierarchy
Blood Coagulation Disorders
MEDLINEPLUS ET 166
Blood Coagulation Disorders
MEDLINEPLUS ET 3115
Blood Coagulation Disorders
MSH MH D001778
Blood Coagulation Disorders
MTH PT 188
Blood Coagulation Disorders
MTH PN NOCODE
Blood Coagulation Disorders
NDFRT PT N0000000575   View In NDFRT Hierarchy
Blood Coagulation Disorders [Disease/Finding]
NDFRT FN N0000000575   View In NDFRT Hierarchy
CLOTTING
CST GT COAGUL DIS
clotting disorder
CSP ET 0438-1873
Clotting disorder
MDR LLT 10064732   View In MDR Hierarchy
Clotting disorder
SNOMEDCT_US SY 64779008   View In SNOMEDCT_US Hierarchy
Clotting disorders
MEDLINEPLUS SY 166
COAG DIS BLOOD
MSH DEV D001778
Coagulation abnormal
MDR OL 10009727   View In MDR Hierarchy
COAGULATION DEFECT
COSTAR PT 188
Coagulation Defect
NICHD SY C2902
Coagulation defect, unspecified
ICD10 PT D68.9   View In ICD10 Hierarchy
Coagulation defect, unspecified
ICD10CM AB D68.9   View In ICD10CM Hierarchy
Coagulation defect, unspecified
ICD10CM PT D68.9   View In ICD10CM Hierarchy
Coagulation defects
ICD9CM HT 286   View In ICD9CM Hierarchy
Coagulation defects
MDR OL 10009729   View In MDR Hierarchy
Coagulation defects
OMIM PTCS MTHU033936
COAGULATION DISORDER
CST PT COAGUL DIS
Coagulation disorder
MDR LLT 10009731   View In MDR Hierarchy
Coagulation Disorder
NCI PT C2902   View In NCI Hierarchy
Coagulation Disorder
NICHD PT C2902
Coagulation disorder
SNOMEDCT_US SY 64779008   View In SNOMEDCT_US Hierarchy
COAGULATION DISORDER (NOS)
CST GT COAGUL DIS
Coagulation disorder (NOS)
MDR OL 10048498   View In MDR Hierarchy
Coagulation disorder NOS
MDR LLT 10009734   View In MDR Hierarchy
Coagulation Disorder, Blood
MSH PM D001778
Coagulation Disorders
CST HT HAL/COAG
Coagulation Disorders, Blood
MSH ET D001778
Coagulation Disorders, Blood
NDFRT SY N0000000575   View In NDFRT Hierarchy
Coagulopathies
MDR HT 10053567   View In MDR Hierarchy
coagulopathy
AOD NP 0000005929
COAGULOPATHY
COSTAR PT U000185
COAGULOPATHY
DXP SY NOCODE
Coagulopathy
FDA PT 1779
Coagulopathy
HPO SY HP:0003256
Coagulopathy
MDR LLT 10009802   View In MDR Hierarchy
Coagulopathy
MDR PT 10009802   View In MDR Hierarchy
Coagulopathy
NICHD SY C2902
Coagulopathy
OMIM PTCS MTHU008649
Coagulopathy
SNOMEDCT_US SY 64779008   View In SNOMEDCT_US Hierarchy
DEFECT COAGULATION (NOS)
CST GT COAGUL DIS
Defect coagulation (NOS)
MDR LLT 10012116   View In MDR Hierarchy
Defective coagulation NOS
MTHICD9 ET 286.9
DIS BLOOD COAG
MSH DEV D001778
DISORDER COAGULATION
CST GT COAGUL DIS
Disorder coagulation
MDR LLT 10013206   View In MDR Hierarchy
Disorder of haemostasis
SNOMEDCT_US SYGB 64779008   View In SNOMEDCT_US Hierarchy
Disorder of haemostatic system
SNOMEDCT_US PTGB 362970003   View In SNOMEDCT_US Hierarchy
Disorder of hemostasis
SNOMEDCT_US SY 64779008   View In SNOMEDCT_US Hierarchy
Disorder of hemostatic system
SNOMEDCT_US PT 362970003   View In SNOMEDCT_US Hierarchy
Disorder of hemostatic system (disorder)
SNOMEDCT_US FN 362970003   View In SNOMEDCT_US Hierarchy
Disorder, Blood Coagulation
MSH PM D001778
Disorder, coagulation
MTHICD9 ET 286.9
Disorder, hemostasis
MTHICD9 ET 286.9
Disorders, Blood Coagulation
MSH ET D001778
Disorders, Blood Coagulation
NDFRT SY N0000000575   View In NDFRT Hierarchy
Relationships with other NCI Metathesaurus Concepts:
Parents | Children | Broader | Narrower | Siblings | Other

Parent Concepts:
Relationship Relationship Definitions Rel. Attribute Relationship Attr. Definitions Name Rel. Source Source List
Parent Hematological Disease AOD
Parent Hematological Disease CSP
Parent CLOTTING DECREASED CST
Parent Coagulation Disorders, General and NEC CST
Parent Hemic and Lymphatic System CST
Parent isa Abnormality of coagulation HPO
Parent Other coagulation defects ICD10CM
Parent Other coagulation defects ICD10
Parent Hematological Disease ICD9CM
Parent Coagulopathies and bleeding diatheses (excl thrombocytopenic) MDR
Parent Hematological Disease MSH
Parent isa Non-Neoplastic Hematologic and Lymphocytic Disorder NCI
Parent Hematological Disease NDFRT
Parent Hematology (discipline) OMIM
Parent isa Disease SNOMEDCT_US

Child Concepts:
Relationship Relationship Definitions Rel. Attribute Relationship Attr. Definitions Name Rel. Source Source List
Child Blood Platelet Disorders AOD
Child hereditary coagulopathy AOD
Child Vascular Purpura AOD
Child Afibrinogenemia CSP
Child Disseminated Intravascular Coagulation CSP
Child Hemophilia A CSP
Child Hemophilia B CSP
Child Inherited Factor II deficiency CSP
Child Multiple Organ Failure CSP
Child von Willebrand Disease CSP
Child anticoagulant disorders CST
Child bleeding time abnormal CST
Child clot retraction abnormal CST
Child Coagulation Disorders, General and NEC CST
Child coagulation factor deficiencies and excesses CST
Child coagulation time abnormal CST
Child inverse_isa Abnormality of prothrombin HPO
Child inverse_isa Abnormality of the common coagulation pathway HPO
Child inverse_isa Abnormality of the extrinsic pathway HPO
Child inverse_isa Abnormality of the intrinsic pathway HPO
Child inverse_isa Abnormality of the protein C anticoagulant pathway HPO
Child inverse_isa Abnormality of von Willebrand factor HPO
Child Acquired Coagulation Factor Deficiency ICD9CM
Child Congenital deficiency of other clotting factors ICD9CM
Child Disseminated Intravascular Coagulation ICD9CM
Child Factor XI Deficiency ICD9CM
Child Hemophilia A ICD9CM
Child Hemophilia B ICD9CM
Child Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors ICD9CM
Child Other coagulation defects ICD9CM
Child von Willebrand Disease ICD9CM
Child Abnormal clotting factor MDR
Child Acquired dysfibrinogenaemia MDR
Child Acute coagulopathy MDR
Child Anaphylactoid syndrome in pregnancy MDR
Child Antiphospholipid Syndrome MDR
Child Blood coagulation MDR
Child Coagulation factor mutation MDR
Child Congenital coagulopathy MDR
Child Congenital hypercoagulation MDR
Child Dilutional coagulopathy MDR
Child Disseminated Intravascular Coagulation in Newborn MDR
Child Disseminated Intravascular Coagulation MDR
Child Dysfibrinogenemia, Congenital MDR
Child Endothelial protein C receptor polymorphism MDR
Child Factor II inhibition MDR
Child Factor II mutation MDR
Child Factor IX inhibition MDR
Child Factor V inhibition MDR
Child Factor V Leiden mutation MDR
Child Factor VII inhibition MDR
Child Factor VIII inhibition MDR
Child Factor X inhibition MDR
Child Factor XIII Inhibition MDR
Child Heparin resistance MDR
Child Hyperfibrinogenemia MDR
Child Hyperfibrinolysis MDR
Child Hyperhomocysteinemia MDR
Child Hyperprothrombinemia MDR
Child Hyperthrombinaemia MDR
Child HYPOCOAGULABLE STATE MDR
Child Methylenetetrahydrofolate reductase deficiency MDR
Child Methylenetetrahydrofolate reductase polymorphism MDR
Child Neonatal coagulation disorder MDR
Child Other coagulation defects MDR
Child Plasminogen activator inhibitor polymorphism MDR
Child Postpartum coagulation defects, delivered, with mention of postpartum complication MDR
Child Postpartum coagulation defects, unspecified as to episode of care or not applicable MDR
Child Postpartum coagulation defects MDR
Child Purpura Fulminans MDR
Child Resistance to activated protein C due to Factor V Leiden MDR
Child Thrombophilia MDR
Child Thrombotic Microangiopathies MDR
Child Von Willebrand's factor inhibition MDR
Child Blood Coagulation Disorders, Inherited MSH
Child Coagulation Protein Disorders MSH
Child Disseminated Intravascular Coagulation MSH
Child Ecchymosis MSH
Child Essential Thrombocythemia MSH
Child Platelet Storage Pool Deficiency MSH
Child Protein S Deficiency Disease MSH
Child Purpura MSH
Child Vitamin K Deficiency MSH
Child inverse_isa Antithrombin III Deficiency NCI
Child inverse_isa Bleeding tendency NCI
Child inverse_isa Coagulation Disorder Related to Liver Dysfunction NCI
Child inverse_isa Coagulation Factor Deficiency Syndrome NCI
Child inverse_isa Congenital Bleeding Disorder NCI
Child inverse_isa Consumptive Coagulopathy NCI
Child inverse_isa Disseminated Intravascular Coagulation NCI
Child inverse_isa Dysfibrinogenemia NCI
Child inverse_isa Hemolytic-Uremic Syndrome NCI
Child inverse_isa High molecular weight kininogen deficiency NCI
Child inverse_isa Hyperfibrinogenemia NCI
Child inverse_isa Immune-Mediated Coagulopathy NCI
Child inverse_isa Plasma Kallikrein Deficiency NCI
Child inverse_isa Plasminogen Activator Inhibitor-1 Deficiency NCI
Child inverse_isa Thrombophilia NCI
Child inverse_isa Thrombotic Microangiopathies NCI
Child inverse_isa Tissue Kallikrein Deficiency NCI
Child inverse_isa von Willebrand Disease NCI
Child Blood Coagulation Disorders, Inherited NDFRT
Child Coagulation Protein Disorders NDFRT
Child Disseminated Intravascular Coagulation NDFRT
Child Ecchymosis NDFRT
Child Essential Thrombocythemia NDFRT
Child Platelet Storage Pool Deficiency NDFRT
Child Protein S Deficiency Disease NDFRT
Child Purpura NDFRT
Child inverse_isa A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 deficiency (ADAMTS13) SNOMEDCT_US
Child inverse_isa Acquired coagulation disorder SNOMEDCT_US
Child inverse_isa Acquired thrombocytopenia SNOMEDCT_US
Child inverse_isa Bleeding disorder due to calcium and DAG-regulated guanine exchange factor-1 deficiency SNOMEDCT_US
Child inverse_isa Bleeding Disorder Due To P2RY12 Defect SNOMEDCT_US
Child inverse_isa Blood coagulation disorder complicating childbirth SNOMEDCT_US
Child inverse_isa Blood coagulation disorder complicating pregnancy SNOMEDCT_US
Child inverse_isa Blood coagulation disorder, categorized by value of screening test SNOMEDCT_US
Child inverse_isa Blood Platelet Disorders SNOMEDCT_US
Child inverse_isa Coagulation Disorder Related to Liver Dysfunction SNOMEDCT_US
Child inverse_isa Coagulation Factor Deficiency Syndrome SNOMEDCT_US
Child inverse_isa Contact factor deficiency SNOMEDCT_US
Child inverse_isa Deficiency of naturally occurring coagulation factor inhibitor SNOMEDCT_US
Child inverse_isa Disorder involving the fibrinolytic system SNOMEDCT_US
Child inverse_isa Disseminated Intravascular Coagulation SNOMEDCT_US
Child inverse_isa Familial hemorrhagic diathesis SNOMEDCT_US
Child inverse_isa Fibrinogen abnormality SNOMEDCT_US
Child inverse_isa Hemorrhagic disorder due to circulating anticoagulants SNOMEDCT_US
Child inverse_isa Hyperheparinemia SNOMEDCT_US
Child inverse_isa Kasabach-Merritt syndrome SNOMEDCT_US
Child inverse_isa Lupus anticoagulant disorder SNOMEDCT_US
Child inverse_isa Neonatal coagulation disorder SNOMEDCT_US
Child inverse_isa Pancytopenia due to antineoplastic chemotherapy SNOMEDCT_US
Child inverse_isa Platelet-Type von Willebrand Disease SNOMEDCT_US
Child inverse_isa Postpartum coagulation defects SNOMEDCT_US
Child inverse_isa Prothrombin complex deficiency SNOMEDCT_US
Child inverse_isa Purpura of skin and or skin-associated mucous membrane co-occurrent and due to coagulation disorder SNOMEDCT_US
Child inverse_isa Purpura SNOMEDCT_US
Child inverse_isa Refractory Thrombocytopenia SNOMEDCT_US
Child inverse_isa Thrombophilia SNOMEDCT_US
Child inverse_isa von Willebrand Disease SNOMEDCT_US

Broader Concepts:
Relationship Relationship Definitions Rel. Attribute Relationship Attr. Definitions Name Rel. Source Source List
Broader Hematological Disease AOD
Broader Hematological Disease CSP
Broader Disease MTH
Broader Hematological Disease MTH
Broader Hemorrhage MTH

Narrower Concepts:
Relationship Relationship Definitions Rel. Attribute Relationship Attr. Definitions Name Rel. Source Source List
Narrower Blood Platelet Disorders AOD
Narrower hereditary coagulopathy AOD
Narrower Vascular Purpura AOD
Narrower Afibrinogenemia CSP
Narrower Disseminated Intravascular Coagulation CSP
Narrower Hemophilia A CSP
Narrower Hemophilia B CSP
Narrower Inherited Factor II deficiency CSP
Narrower Multiple Organ Failure CSP
Narrower von Willebrand Disease CSP
Narrower mapped_from Bleeding Disorder due to Defective Thromboxane A2 Receptor MSH
Narrower mapped_from Bleeding Disorder, East Texas Type MSH
Narrower mapped_from Car Factor Deficiency MSH
Narrower mapped_from Fibrinolytic Defect MSH
Narrower mapped_from Globulin Anomaly involving Beta (2A)-Globulin MSH
Narrower mapped_from High molecular weight kininogen deficiency MSH
Narrower mapped_from Hyperheparinemia MSH
Narrower mapped_from Plasma Clot Retraction Factor, Deficiency of MSH
Narrower mapped_from Prekallikrein deficiency MSH
Narrower mapped_from Prostaglandin-Endoperoxide Synthase 1 Deficiency, Platelet MSH
Narrower mapped_from Scott Syndrome MSH
Narrower mapped_from Thromboxane synthetase deficiency MSH
Narrower Acquired Coagulation Factor Deficiency MTH
Narrower Afibrinogenemia MTH
Narrower Car Factor Deficiency MTH
Narrower Coagulation Factor Deficiency Syndrome MTH
Narrower Congenital hypofibrinogenemia MTH
Narrower Decreased fibrinolysis (finding) MTH
Narrower Disseminated Intravascular Coagulation MTH
Narrower Factor II deficiency MTH
Narrower Factor V And Factor VIII, Combined Deficiency Of, With Normal Protein C And Protein C Inhibitor MTH
Narrower Factor VII Deficiency MTH
Narrower Hemophilia A MTH
Narrower Hemophilia B MTH
Narrower Hemorrhagic disorder due to circulating anticoagulants MTH
Narrower Other coagulation defects MTH
Narrower Postpartum coagulation defects MTH
Narrower Prothrombin time increased MTH
Narrower Thrombophilia MTH
Narrower Vascular Hemostatic Disorders MTH
Narrower von Willebrand Disease MTH

Sibling Concepts:
Relationship Relationship Definitions Rel. Attribute Relationship Attr. Definitions Name Rel. Source Source List
Sibling Anemia AOD
Sibling Blood Group Incompatibility AOD
Sibling Bone Marrow Diseases AOD
Sibling congenital blood disorder AOD
Sibling Leukocyte Disorders AOD
Sibling Pancytopenia AOD
Sibling Thrombosis AOD
Sibling Anemia CCS_10
Sibling Coagulation and hemorrhagic disorders CCS_10
Sibling Leukocyte Disorders CCS_10
Sibling Other hematologic conditions CCS_10
Sibling Anemia CSP
Sibling Blood Group Incompatibility CSP
Sibling Blood Protein Disorders CSP
Sibling blood/lymphatic neoplasm CSP
Sibling Calcium Metabolism Disorders CSP
Sibling Cardiovascular Diseases CSP
Sibling Communication impairment CSP
Sibling congenital blood disorder CSP
Sibling Congenital Disorders CSP
Sibling Connective Tissue Diseases CSP
Sibling Dermatologic disorders CSP
Sibling developmental disease/disorder CSP
Sibling Digestive System Disorders CSP
Sibling disease/therapy duration CSP
Sibling Disorder of eye CSP
Sibling Ear Diseases CSP
Sibling Endocrine System Diseases CSP
Sibling Hematologic Tests CSP
Sibling Hematological Disease CSP
Sibling Hemorrhagic Disorders CSP
Sibling Hereditary Diseases CSP
Sibling Hernia CSP
Sibling Hyperlipidemia CSP
Sibling Hyperviscosity syndrome CSP
Sibling Hypolipidemia CSP
Sibling immunohematology CSP
Sibling Infectious Disorder CSP
Sibling Leukocyte Disorders CSP
Sibling Lymphatic Diseases CSP
Sibling Malignant Neoplasms CSP
Sibling manifestations of immunopathology CSP
Sibling Mental disorders CSP
Sibling Metabolic Disorder CSP
Sibling Musculoskeletal Diseases CSP
Sibling nervous system disorder CSP
Sibling Nutrition Disorders CSP
Sibling orphan disease/drug CSP
Sibling Pathology processes CSP
Sibling Plant Diseases CSP
Sibling reproductive system disorder CSP
Sibling Respiration Disorders CSP
Sibling Specific enzyme deficiency CSP
Sibling Syndrome CSP
Sibling Traumatic injury CSP
Sibling Urologic Diseases CSP
Sibling Venous blood sampling CSP
Sibling Abnormal platelets CST
Sibling Abnormality of red blood cells CST
Sibling ANTICOAGULANT EFFECT INCREASED CST
Sibling Bone Marrow Abnormalities NEC CST
Sibling Bone marrow depression CST
Sibling CLOTTING DECREASED CST
Sibling CLOTTING INCREASED CST
Sibling Decreased platelet count CST
Sibling Disseminated Intravascular Coagulation Adverse Event CST
Sibling Ecchymosis CST
Sibling Fibrinogen Decreased CST
Sibling FIBRINOPENIA CST
Sibling Hemic, General and NEC CST
Sibling Hemoglobinopathy CST
Sibling Hemorrhage CST
Sibling Increased fibrinolysis (finding) CST
Sibling Increased number of platelets CST
Sibling Leukopenia CST
Sibling Lymphatic Diseases CST
Sibling Pathologic Hemolysis CST
Sibling Petechiae CST
Sibling Platelet adhesiveness decreased CST
Sibling Prolonged bleeding time CST
Sibling Prolonged whole-blood clotting time CST
Sibling Prothrombin level decreased CST
Sibling Purpura Fulminans CST
Sibling Purpura, Thrombotic Thrombocytopenic CST
Sibling Purpura CST
Sibling RBC count low CST
Sibling Red blood cell count raised CST
Sibling Reticulo-endothelial Disorders CST
Sibling RETRACTION CLOT RETARD CST
Sibling Splenic Disorder CST
Sibling Thrombin decreased CST
Sibling Thrombocyte Abnormalities (Platelets or Megakaryocytes) CST
Sibling Thrombocytopenia CST
Sibling Thrombocytopenic purpura CST
Sibling Thromboplastin decreased CST
Sibling Vascular Purpura CST
Sibling White blood cell abnormality CST
Sibling Abnormality of fibrinolysis HPO
Sibling Partial thromboplastin time increased (finding) HPO
Sibling Prolonged whole-blood clotting time HPO
Sibling Thrombophilia HPO
Sibling Acquired Coagulation Factor Deficiency ICD10CM
Sibling Factor XI Deficiency ICD10CM
Sibling Hemorrhagic disorder due to circulating anticoagulants ICD10CM
Sibling Hereditary deficiency of other clotting factors ICD10CM
Sibling Other specified coagulation defects ICD10CM
Sibling Other Thrombophilia ICD10CM
Sibling Thrombophilia, hereditary ICD10CM
Sibling von Willebrand Disease ICD10CM
Sibling Acquired Coagulation Factor Deficiency ICD10
Sibling Factor XI Deficiency ICD10
Sibling Hemorrhagic disorder due to circulating anticoagulants ICD10
Sibling Hereditary deficiency of other clotting factors ICD10
Sibling Other specified coagulation defects ICD10
Sibling Other Thrombophilia ICD10
Sibling Thrombophilia, hereditary ICD10
Sibling von Willebrand Disease ICD10
Sibling Acquired Hemolytic Anemia ICD9CM
Sibling Aplastic anemia and other bone marrow failure syndromes ICD9CM
Sibling Hereditary Hemolytic Anemia ICD9CM
Sibling Iron deficiency anemia ICD9CM
Sibling Leukocyte Disorders ICD9CM
Sibling Other anaemias ICD9CM
Sibling Other deficiency anemias ICD9CM
Sibling Other diseases of blood and blood-forming organs ICD9CM
Sibling Purpura and other haemorrhagic conditions ICD9CM
Sibling Acquired complement deficiency disease MDR
Sibling Adrenal Gland Myelolipoma MDR
Sibling Bleeding tendency MDR
Sibling Bone Marrow Diseases MDR
Sibling BONE MARROW GRANULOMAS MDR
Sibling Bone marrow haemorrhage MDR
Sibling Bone marrow infiltration MDR
Sibling Bone marrow ischemia MDR
Sibling Bone marrow necrosis MDR
Sibling Bone marrow oedema syndrome MDR
Sibling Bone marrow transplant rejection MDR
Sibling Carboxyhemoglobinemia MDR
Sibling Coagulation Factor Deficiency Syndrome MDR
Sibling Complement Deficiency MDR
Sibling Congenital Hematological Disorder MDR
Sibling Congenital Methemoglobinemia MDR
Sibling Cutaneous extramedullary haemopoiesis MDR
Sibling Cutaneous T-cell dyscrasia MDR
Sibling Dysglobulinemia MDR
Sibling Edema of bone marrow MDR
Sibling Engraftment Syndrome MDR
Sibling Erythrosis MDR
Sibling Extramedullary Hematopoiesis Function MDR
Sibling Haematotoxicity MDR
Sibling Haemoconcentration MDR
Sibling Hematological disorders of fetus and newborn MDR
Sibling Hemodilution MDR
Sibling Histiocytosis haematophagic MDR
Sibling Hypergammaglobulinemia MDR
Sibling Hyperglobulinemia MDR
Sibling Hyperviscosity syndrome MDR
Sibling Hypoglobulinemia MDR
Sibling Mast cell activation syndrome, NOS MDR
Sibling Mastocytosis, Systemic MDR
Sibling Mastocytosis MDR
Sibling Melanaemia MDR
Sibling Metastatic Malignant Neoplasm in the Bone Marrow MDR
Sibling Methemoglobinemia MDR
Sibling Methemoglobinuria MDR
Sibling Other diseases of blood and blood-forming organs MDR
Sibling Other specified diseases of blood and blood-forming organs MDR
Sibling Other specified transient hematological disorders of fetus or newborn MDR
Sibling Placental transfusion syndromes MDR
Sibling Post transplant distal limb syndrome MDR
Sibling Purpuras (excl thrombocytopenic) MDR
Sibling Reticulin Fibrosis of the Bone Marrow MDR
Sibling SERUM COMPLEMENT DECREASED MDR
Sibling Sulfhemoglobinemia MDR
Sibling Transfusion Reaction MDR
Sibling Unspecified hematological disorder specific to newborn MDR
Sibling Anemia MSH
Sibling Blood Platelet Disorders MSH
Sibling Blood Protein Disorders MSH
Sibling Bone Marrow Diseases MSH
Sibling Erythroblastosis, Fetal MSH
Sibling Hematologic Neoplasms MSH
Sibling Hemoglobinopathy MSH
Sibling Hemorrhagic Disorders MSH
Sibling Leukocyte Disorders MSH
Sibling Methemoglobinemia MSH
Sibling Myelodysplastic Syndrome MSH
Sibling Pancytopenia MSH
Sibling Polycythemia MSH
Sibling Pregnancy Complications, Hematologic MSH
Sibling Sulfhemoglobinemia MSH
Sibling Syndrome MSH
Sibling Thrombophilia MSH
Sibling Transfusion Medicine MSH
Sibling Transfusion Reaction MSH
Sibling Abnormalities, Radiation-Induced NCI
Sibling Amegakaryocytosis NCI
Sibling Anemia NCI
Sibling Benign Lymphoproliferative Disorder NCI
Sibling Blood Platelet Disorders NCI
Sibling Cancer-Related Condition NCI
Sibling Congenital Hematological Disorder NCI
Sibling Cyclic neutropenia NCI
Sibling Disorder by Site NCI
Sibling Evans syndrome NCI
Sibling Experimental Hematology NCI
Sibling Glanzmann Thrombasthenia NCI
Sibling Hamartoma NCI
Sibling Hematologic Neoplasms NCI
Sibling Hematology, Other NCI
Sibling Hereditary Diseases NCI
Sibling Hyperplasia NCI
Sibling Lifestyle-related condition NCI
Sibling Lymphoproliferative Disorders NCI
Sibling Mental disorders NCI
Sibling Methemoglobinemia NCI
Sibling Neonatal Leukopenia NCI
Sibling Neoplasm of unspecified nature, site unspecified NCI
Sibling Non-Neoplastic Disorder NCI
Sibling Non-Neoplastic Hematologic and Lymphocytic Disorder NCI
Sibling Paroxysmal nocturnal hemoglobinuria NCI
Sibling Pediatric Disorder NCI
Sibling Polycythemia NCI
Sibling polyps NCI
Sibling Premalignant Hematologic Condition NCI
Sibling Pure Red-Cell Aplasia NCI
Sibling Rare Disorder NCI
Sibling Sinus histiocytosis NCI
Sibling Spherocytosis NCI
Sibling Syndrome NCI
Sibling Thrombocytopenic purpura NCI
Sibling Anemia NDFRT
Sibling Blood Platelet Disorders NDFRT
Sibling Blood Protein Disorders NDFRT
Sibling Bone Marrow Diseases NDFRT
Sibling Hematologic Neoplasms NDFRT
Sibling Hemorrhagic Disorders NDFRT
Sibling Leukocyte Disorders NDFRT
Sibling Methemoglobinemia NDFRT
Sibling Myelodysplastic Syndrome NDFRT
Sibling Pancytopenia NDFRT
Sibling Polycythemia NDFRT
Sibling Pregnancy Complications, Hematologic NDFRT
Sibling Sulfhemoglobinemia NDFRT
Sibling Syndrome NDFRT
Sibling Thrombophilia NDFRT
Sibling Transfusion Reaction NDFRT
Sibling 'Leukemoid' granulocytosis OMIM
Sibling Abnormal blood coagulation studies (prolonged PT and PTT) OMIM
Sibling Abnormal platelet maturation OMIM
Sibling Abnormal platelet morphology with paucity of granules (in some patients) OMIM
Sibling Abnormal platelets with giant morphology OMIM
Sibling Abnormal platelets OMIM
Sibling Abnormal RBC morphology (anisocytosis, poikilocytes, acanthocytes) (in some patients) OMIM
Sibling Abnormality of coagulation OMIM
Sibling Absence of Hb H inclusions in red blood cells OMIM
Sibling Absence of Lutheran antigen on red blood cells OMIM
Sibling Absence of megakaryocytes in bone marrow OMIM
Sibling Absence of platelet dense bodies OMIM
Sibling Absent bone marrow myeloid elements OMIM
Sibling Absent dense bodies in platelets OMIM
Sibling Absent neutrophil inclusions OMIM
Sibling Absent or hypoplastic megakaryocytes OMIM
Sibling Absent platelet aggregation response to epinephrine OMIM
Sibling Absent platelet delta granules OMIM
Sibling Acanthocytes OMIM
Sibling Acanthocytosis OMIM
Sibling Acute hemolytic transfusion reaction when transfused with Vel-positive blood OMIM
Sibling Alpha polypeptide hemoglobin chain OMIM
Sibling Alpha-thalassemia silent carrier (3 normal genes) OMIM
Sibling Alpha-thalassemia with fatal Hb Bart's hydrops fetalis (No normal gene) OMIM
Sibling Alpha-thalassemia with microcytosis (2 normal genes) OMIM
Sibling Alpha-thalassemia with microcytosis and hemolysis, Hb H disease (1 normal gene) OMIM
Sibling alpha-Thalassemia OMIM
Sibling Amegakaryocytic thrombocytopenia OMIM
Sibling Amelioration of SS disease (e.g. Hb Memphis 141800.0096) OMIM
Sibling Amemia OMIM
Sibling Anemia (associated with mutation in the COX10 gene) OMIM
Sibling Anemia (in some patients) OMIM
Sibling Anemia (in some) OMIM
Sibling Anemia (less common) OMIM
Sibling Anemia (not responsive to pyridoxine supplementation) OMIM
Sibling Anemia (patient A) OMIM
Sibling Anemia (rare) OMIM
Sibling Anemia (with bone marrow involvement) OMIM
Sibling Anemia due to poor nutrition OMIM
Sibling Anemia may be exacerbated during infection or pregnancy OMIM
Sibling Anemia requiring transfusions OMIM
Sibling Anemia, congenital hypoplastic, moderate-severe (normochromic, macrocytic) OMIM
Sibling Anemia, corticosteroid-sensitive OMIM
Sibling Anemia, dyserythropoietic (in some patients) OMIM
Sibling Anemia, Hemolytic, Congenital Nonspherocytic OMIM
Sibling Anemia, Macrocytic OMIM
Sibling Anemia, mild (in some patients) OMIM
Sibling Anemia, persistent OMIM
Sibling Anemia, severe congenital (in some patients) OMIM
Sibling ANEMIA, SEVERE OMIM
Sibling Anemia, unresponsive to oral iron and only partially responsive to parenteral iron OMIM
Sibling Anemia OMIM
Sibling Aniso-poikilocytosis on blood smear OMIM
Sibling Anisocytosis OMIM
Sibling Anisopoikilocytosis OMIM
Sibling Anti-H in serum OMIM
Sibling Antiphospholipid syndrome Hemolytic anemia OMIM
Sibling Antithrombin III decreased OMIM
Sibling Antithrombin III deficiency (in 1 patient) OMIM
Sibling Antithrombin III Deficiency OMIM
Sibling Aplastic anemia (in some patients) OMIM
Sibling Aplastic Anemia OMIM
Sibling Associated with iron deficiency anemia OMIM
Sibling Asymptomatic (easy bruisability, postoperative hemorrhage) OMIM
Sibling Asymptomatic bleeding tendencies (petechiae, epistaxis, mucosal bleeding) OMIM
Sibling Asymptomatic to mild bleeding episodes (epistaxis, postoperative hemorrhage) OMIM
Sibling Atypical lymphocytosis OMIM
Sibling Autohemolysis OMIM
Sibling Autoimmune Cytopenia OMIM
Sibling Autoimmune hemolytic anemia (in some patients) OMIM
Sibling Autoimmune hemolytic anemia (rare) OMIM
Sibling Autoimmune hemolytic anemia OMIM
Sibling Autoimmune neutropenia OMIM
Sibling Basophilic Stippling OMIM
Sibling Benign neutropenia OMIM
Sibling Bimodal erythrocyte volume distribution curve (in some patients) OMIM
Sibling Bite cell (cell) OMIM
Sibling Bleeding associated with peptic ulcer disease OMIM
Sibling Bleeding defect due to decreased plasminogen activator inhibitor-1 OMIM
Sibling Bleeding due to vitamin K deficiency (1 patient) OMIM
Sibling Bleeding episodes (epistaxis, menorrhagia, ecchymosis) OMIM
Sibling Bleeding episodes OMIM
Sibling Bleeding tendency (e.g., epistaxis) OMIM
Sibling Bleeding tendency due to defect in prothrombin and inability to form fibrin clot OMIM
Sibling Bleeding tendency due to platelet defect OMIM
Sibling Bleeding tendency, mild, mucocutaneous OMIM
Sibling Bleeding tendency, mild OMIM
Sibling Bleeding tendency OMIM
Sibling Bleeding time normal to mildly prolonged OMIM
Sibling Bleeding, mild OMIM
Sibling Bombay (hh) blood phenotype OMIM
Sibling Bone marrow aspirate shows normal cellularity and reticular fibrosis OMIM
Sibling Bone marrow biopsy shows erythrocyte hypocellularity OMIM
Sibling Bone marrow biopsy shows erythroid hyperplasia OMIM
Sibling Bone marrow biopsy shows increased eosinophils without myeloblasts OMIM
Sibling Bone marrow biopsy shows increased numbers of normal to small megakaryocytes OMIM
Sibling Bone marrow biopsy shows megaloblastic erythroblasts OMIM
Sibling Bone marrow biopsy shows megaloblastic erythroid hyperplasia OMIM
Sibling Bone marrow contains lipid-laden macrophages OMIM
Sibling Bone marrow depression OMIM
Sibling Bone marrow failure (1 patient) OMIM
Sibling Bone marrow failure (classic feature, NOLA3 patient) OMIM
Sibling Bone marrow failure (in some patients) OMIM
Sibling Bone marrow failure, progressive OMIM
Sibling Bone Marrow Failure OMIM
Sibling bone marrow fibrosis OMIM
Sibling Bone marrow foam cells (type II) OMIM
Sibling Bone marrow hypercellularity OMIM
Sibling Bone marrow hypocellularity OMIM
Sibling Bone marrow involvement may cause pancytopenia OMIM
Sibling Bone marrow may show hemophagocytosis OMIM
Sibling Bone marrow megaloblastic (finding) OMIM
Sibling BONE MARROW RINGED SIDEROBLASTS OMIM
Sibling Bone marrow shows abnormal development of neutrophils OMIM
Sibling Bone marrow shows decreased erythroid progenitors OMIM
Sibling Bone marrow shows erythroid dysplasia OMIM
Sibling Bone marrow shows Gaucher cells OMIM
Sibling Bone marrow shows increased numbers of abnormal megakaryocytes OMIM
Sibling Bone marrow smear shows erythroid hyperplasia OMIM
Sibling Bone-marrow foam cells OMIM
Sibling Burr cell OMIM
Sibling Cation leak OMIM
Sibling CD43 (sialophorin) defectively expressed on surface of blood cells OMIM
Sibling Chronic anemia (in 1 patient) OMIM
Sibling Chronic disseminated intravascular coagulation OMIM
Sibling Chronic hemolytic anemia OMIM
Sibling Chronic Lymphocytic Leukemia OMIM
Sibling Circulating orthochromatic erythroblasts OMIM
Sibling Coagulation defect due to decreased liver function OMIM
Sibling Coagulation defects (1 patient) OMIM
Sibling Coagulation defects (in some patients) OMIM
Sibling Coagulation defects secondary to liver failure OMIM
Sibling Coagulation Factor Deficiency Syndrome OMIM
Sibling Coagulopathy (in some patients) OMIM
Sibling Coagulopathy due to hepatic failure OMIM
Sibling Coagulopathy due to liver dysfunction OMIM
Sibling Coagulopathy during episodes OMIM
Sibling Coagulopathy in those with liver failure OMIM
Sibling Coagulopathy secondary to liver disease OMIM
Sibling Coagulopathy secondary to liver failure OMIM
Sibling Coagulopathy, mild (in some patients) OMIM
Sibling Coarse granulocyte chromatin OMIM
Sibling Congenital bleeding diathesis OMIM
Sibling Congenital Heinz body anemia (e.g. Hb Toyama 141800.0152) OMIM
Sibling Congenital hypoplastic anemia OMIM
Sibling Congenital neutropenia OMIM
Sibling Congenital thrombocytopenia OMIM
Sibling Cytopenia OMIM
Sibling Dacryocyte (cell) OMIM
Sibling Decreased beta-thromboglobulin OMIM
Sibling Decreased beta-tubulin in platelets OMIM
Sibling Decreased bone marrow cellularity OMIM
Sibling Decreased coagulation factors IX, XI, XII OMIM
Sibling Decreased erythrocyte potassium OMIM
Sibling Decreased erythropoiesis OMIM
Sibling Decreased erythropoietic response under hypoxic conditions OMIM
Sibling Decreased euglobin lysis time OMIM
Sibling Decreased expression of CD44 and AQP1 on red cells OMIM
Sibling Decreased F2 activity OMIM
Sibling Decreased F2 antigen levels (in some patients) OMIM
Sibling Decreased hemoglobin oxygen saturation OMIM
Sibling Decreased levels of erythrocyte cytochrome B5 OMIM
Sibling Decreased mean platelet volume (MPV) OMIM
Sibling Decreased multimerin OMIM
Sibling Decreased myeloperoxidase activity in neutrophils and monocytes OMIM
Sibling Decreased number of small megakaryocytes (1 patient) OMIM
Sibling Decreased osmotic fragility OMIM
Sibling Decreased oxygen-binding capacity of hemoglobin OMIM
Sibling Decreased platelet count OMIM
Sibling Decreased platelet expression of GP6 OMIM
Sibling Decreased platelet function OMIM
Sibling Decreased serum coagulation factors OMIM
Sibling Decreased serum thromboxane B2 OMIM
Sibling Defective NK cell activity OMIM
Sibling Defective NK cell degranulation OMIM
Sibling Defective platelet activation and aggregation in response to collagen OMIM
Sibling Defective platelet adhesion with normal platelet count OMIM
Sibling Defective platelet aggregation in response to ADP OMIM
Sibling Defective platelet aggregation in response to arachidonic acid OMIM
Sibling Defective platelet binding to collagen OMIM
Sibling Defective platelet calcium mobilization OMIM
Sibling Degraded platelet alpha-granule proteins OMIM
Sibling Dehydrated-appearing red cells OMIM
Sibling Dimorphic appearance of red cells on smear (in some patients) OMIM
Sibling Disorders of Porphyrin Metabolism OMIM
Sibling Disseminated intravascular coagulation, episodic OMIM
Sibling Dyserythropoiesis in bone marrow (1 patient) OMIM
Sibling dyserythropoietic anemia OMIM
Sibling Dyserythropoietic bone marrow biopsy OMIM
Sibling Dysplastic changes in all cell lineages in the bone marrow OMIM
Sibling Dysplastic erythroblasts with internuclear chromatin strands OMIM
Sibling Eccentrocytes (in some patients) OMIM
Sibling Echinocytosis OMIM
Sibling Ektacytometric osmotic gradient curve shifted to the left OMIM
Sibling Electron microscopy shows iron-loaded mitochondria OMIM
Sibling Elevated erythrocyte adenosine deaminase activity OMIM
Sibling Elevated fetal hemoglobin (HbF) OMIM
Sibling Elevated HbA(2) OMIM
Sibling Elevated HbF OMIM
Sibling Elevated mean corpuscular volume (MCV) OMIM
Sibling Elevated reticulocyte count OMIM
Sibling Elevated serum thrombopoietin (TPO) OMIM
Sibling Elevated thrombopoietin (TPO) OMIM
Sibling Elliptocytosis (in some patients, segregated independently) OMIM
Sibling Elliptocytosis, Hereditary OMIM
Sibling Emperipolesis OMIM
Sibling Eosinophilia OMIM
Sibling Episodic bleeding OMIM
Sibling Episodic hemolytic anemia OMIM
Sibling Epistaxis OMIM
Sibling Erythroblast morphologic abnormalities OMIM
Sibling Erythroblasts show atypical cytoplasmic inclusions OMIM
Sibling Erythrocyte Adenylate Kinase Deficiency OMIM
Sibling Erythrocyte macrocytosis OMIM
Sibling Erythrocyte membrane instability OMIM
Sibling erythrocyte morphology - elliptocytes (lab test) OMIM
Sibling Erythrocytes have defects in cation permeability OMIM
Sibling Erythrocytosis OMIM
Sibling Erythroid hyperplasia seen on bone marrow biopsy OMIM
Sibling Erythropoietic hyperplasia of bone marrow OMIM
Sibling Essential Thrombocythemia OMIM
Sibling Extramedullary erythropoiesis OMIM
Sibling Extramedullary Hematopoiesis Function OMIM
Sibling Factor V Deficiency OMIM
Sibling Factor XI Deficiency OMIM
Sibling Foam cells on bone marrow biopsy OMIM
Sibling Folate-responsive megaloblastic anemia OMIM
Sibling Fragmented erythrocytes OMIM
Sibling Fragmented red cells OMIM
Sibling Gaucher cells in bone marrow OMIM
Sibling Generalized bone marrow fibrosis OMIM
Sibling Giant inclusion bodies present in most granulated cells OMIM
Sibling Giant platelet (morphologic abnormality) OMIM
Sibling Giant platelet alpha granules (peripheral blood) OMIM
Sibling Glanzmann Thrombasthenia OMIM
Sibling Granulocyte hypocellularity (in some patients) OMIM
Sibling Granulocytopenia, intermittent (patient A) OMIM
Sibling Gray platelets OMIM
Sibling Gray polymorphonuclear neutrophils OMIM
Sibling Gray-to-gray-blue platelet on Wright-Giemsa stain OMIM
Sibling H antigen absent on red cells OMIM
Sibling Hb H inclusions in red blood cells OMIM
Sibling Hematocrit increased OMIM
Sibling Hematomas after trauma or injury OMIM
Sibling Hematopoietic toxicity develops on standard doses of thiopurine drugs OMIM
Sibling Hemighosts OMIM
Sibling Hemoglobin Decreased OMIM
Sibling Hemoglobin F Increased OMIM
Sibling Hemoglobin increased OMIM
Sibling Hemolysis (e.g. Hb Koelliker 141800.0083) OMIM
Sibling Hemolysis Biological Process OMIM
Sibling Hemolytic anemia (1 patient) OMIM
Sibling Hemolytic anemia (in some patients) OMIM
Sibling Hemolytic anemia (variable) OMIM
Sibling Hemolytic anemia in approximately 60% of patients OMIM
Sibling Hemolytic anemia, mild to moderate OMIM
Sibling Hemolytic Anemia OMIM
Sibling Hemophilia B OMIM
Sibling Hemorrhage OMIM
Sibling Hemorrhagic diathesis, mild OMIM
Sibling Hepatosplenomegaly, with extramedullary hematopoiesis (rare) OMIM
Sibling Hereditary Factor XIII Deficiency OMIM
Sibling Hereditary Hemolytic Anemia OMIM
Sibling Heterochromatin clumps with spongy, 'Swiss cheese' appearance OMIM
Sibling High blood oxygen saturation of hemoglobin (10% higher mean than the lowest values of population studied) OMIM
Sibling High sodium/low potassium red blood cells OMIM
Sibling Howell-Jolly Bodies OMIM
Sibling Hypercellular bone marrow with erythroid hyperplasia OMIM
Sibling Hypercellular Bone Marrow OMIM
Sibling Hypereosinophilia OMIM
Sibling Hypermature neutrophils have condensed nuclei connected by long, stringy filaments and vacuolated cytoplasm OMIM
Sibling Hypersegmented neutrophils (1 patient) OMIM
Sibling Hypersegmented neutrophil OMIM
Sibling Hypersensitivity of erythroid colony-forming units to erythropoietin (EPO, 133170) OMIM
Sibling Hypersplenism OMIM
Sibling Hyperuricemia OMIM
Sibling Hypochromia OMIM
Sibling Hypochromic anemia OMIM
Sibling Hypoglycosylation of red blood cell membranes OMIM
Sibling Hypolobulated (bilobed or rod-like) granulocyte nuclei (heterozygote) OMIM
Sibling Hypolobulated megakaryocytes in the bone marrow OMIM
Sibling Hypolobulation of granulocyte nuclei (Pelger-Huet anomaly) OMIM
Sibling Hypoplastic anemia OMIM
Sibling Hypoplastic myelodysplasia OMIM
Sibling Idiopathic thrombocytopenia OMIM
Sibling Imbalanced hemoglobin chain synthesis OMIM
Sibling Impaired coagulation due to malnutrition OMIM
Sibling Impaired platelet aggregation (in some patients) OMIM
Sibling Impaired platelet aggregation and spreading OMIM
Sibling Impaired platelet aggregation OMIM
Sibling Impaired platelet function OMIM
Sibling Impaired release of platelet adenosine diphosphate (ADP) OMIM
Sibling Inappropriately low reticulocyte counts OMIM
Sibling Increase in blood monocytes (2-3 times normal) OMIM
Sibling Increased absolute neutrophil count (ANC) within 0.0-0.2 x 10(9)/l OMIM
Sibling Increased alpha/beta globin ratio in reticulocytes OMIM
Sibling Increased autohemolysis OMIM
Sibling Increased bleeding (menorrhagia, gastrointestinal bleeding, hemarthroses) OMIM
Sibling Increased bleeding after trauma, surgery, or injury OMIM
Sibling Increased bleeding tendency (in 1 patient) OMIM
Sibling Increased bleeding tendency due to platelet dysfunction OMIM
Sibling Increased bleeding tendency, moderate to severe OMIM
Sibling Increased erythrocyte adenosine deaminase activity OMIM
Sibling Increased erythrocyte sodium OMIM
Sibling Increased erythrocyte zinc- and metal-free protoporphyrin OMIM
Sibling Increased fibrinolysis (finding) OMIM
Sibling Increased mean corpuscular hemoglobin (MCH) OMIM
Sibling Increased mean corpuscular hemoglobin concentration (MCHC) OMIM
Sibling Increased mean corpuscular hemoglobin concentration OMIM
Sibling Increased mean corpuscular volume (MCV) OMIM
Sibling Increased mean platelet volume OMIM
Sibling Increased megakaryocyte colony forming units (CFU-MK) OMIM
Sibling Increased megakaryocyte precursor cells OMIM
Sibling Increased micromegakaryocytes (bone marrow) OMIM
Sibling Increased myeloid precursor cells OMIM
Sibling Increased myeloid to erythroid ratio (M:E ratio) 10:1-200:1 OMIM
Sibling Increased number of abnormal megakaryocytes seen on bone marrow biopsy OMIM
Sibling Increased osmotic fragility OMIM
Sibling Increased passive permeability of potassium through red cell membrane at reduced temperatures OMIM
Sibling Increased plasma thrombopoietin (TPO) OMIM
Sibling Increased platelet content of PLAU OMIM
Sibling Increased promyelocytes OMIM
Sibling Increased red blood cell mass OMIM
Sibling Increased red blood cell membrane permeability to univalent cations OMIM
Sibling Increased red cell hemolysis by shear stress OMIM
Sibling Increased red cell membrane cation permeability at cold temperatures (in some patients) OMIM
Sibling Increased red cell osmotic fragility OMIM
Sibling Increased red cell osmotic resistance OMIM
Sibling Increased serum ferritin OMIM
Sibling Increased sister chromatid exchange OMIM
Sibling Increased tendency to bruise OMIM
Sibling Increased total white blood count OMIM
Sibling Ineffective erythropoiesis OMIM
Sibling Intermittent thrombocytopenia OMIM
Sibling Internuclear chromatin bridges OMIM
Sibling Intracytoplasmic vacuoles in eosinophils, neutrophils and lymphocytes OMIM
Sibling Iron deficiency (in some patients) OMIM
Sibling Iron deficiency anemia (adults) OMIM
Sibling Iron deficiency anemia OMIM
Sibling Iron deficiency OMIM
Sibling Iron-deficiency anemia (in some patients) OMIM
Sibling Kasabach-Merritt syndrome OMIM
Sibling Knizocyte OMIM
Sibling Lack of dense granules in platelets OMIM
Sibling Large agranular platelets OMIM
Sibling Large platelets (in some patients) OMIM
Sibling Large, spherical platelets OMIM
Sibling Leptocyte OMIM
Sibling Leukemoid Reaction OMIM
Sibling Leukocyte inclusion bodies (Dohle-like bodies) OMIM
Sibling Leukocytosis (before age 50) OMIM
Sibling Leukocytosis (mean leukocyte count 18.7 x 10(9)/L) OMIM
Sibling Leukocytosis with eosinophilia during stage 1 OMIM
Sibling Leukocytosis with predominant granulocytosis (20,000-100,000 /mm3) common OMIM
Sibling Leukocytosis OMIM
Sibling Leukoerythroblastic Anemia OMIM
Sibling Leukopenia (less common) OMIM
Sibling Leukopenia OMIM
Sibling Lewis a- and b- negative cells OMIM
Sibling Lipid droplets in granulocytes OMIM
Sibling Lipid inclusions in lymphocytes OMIM
Sibling Low peripheral neutrophil counts (absolute neutrophil count less than 500/microliter) OMIM
Sibling Low serum transferrin OMIM
Sibling Low to low-normal platelet count OMIM
Sibling Low to normal reticulocyte count OMIM
Sibling Low-normal platelet count in carrier females OMIM
Sibling Low-to-normal platelet count (45 x 10(9)/l) OMIM
Sibling Lupus anticoagulant (in some patients) OMIM
Sibling Lutheran negative phenotype OMIM
Sibling Lymphopenia, mild OMIM
Sibling Lymphopenia OMIM
Sibling Macrocytic anemia (1 patient) OMIM
Sibling Macrocytic anemia (folate or rarely B12 deficiency) OMIM
Sibling Macrocytic anemia in manifesting females OMIM
Sibling Macrocytic erythrocyte OMIM
Sibling Macrocytic hemolytic anemia, appears in infancy (in 1 family) OMIM
Sibling Macrocytosis (in some patients) OMIM
Sibling Macrocytosis after 24 hours on ice (in some patients) OMIM
Sibling Macrocytosis OMIM
Sibling Macrospherocytosis on cold storage OMIM
Sibling Macrothrombocytes occasionally noted in carrier female peripheral blood smear OMIM
Sibling Macrothrombocytopenia OMIM
Sibling Maturation arrest of neutrophil precursors seen on bone marrow biopsy OMIM
Sibling MCV - raised OMIM
Sibling Mean corpuscular volume may mildly increased or normal OMIM
Sibling Median platelet volume 15.5fl OMIM
Sibling Medullary blast count of less than 5% OMIM
Sibling Megakaryocytes are abnormally stretched along bone marrow sinuses OMIM
Sibling Megakaryocytes have dysplastic features OMIM
Sibling Megakaryocytes Increased in Bone Marrow OMIM
Sibling Megakaryocytes show large and irregular bleb protrusions OMIM
Sibling Megakaryocytes show ultrastructural defects with abnormal membranes OMIM
Sibling Megakaryocytes with hypolobulated nuclei or separated nuclei OMIM
Sibling Megakaryocytopenia OMIM
Sibling Megaloblastic anemia, chronic, relapsing OMIM
Sibling Megaloblastic Anemia OMIM
Sibling Megaloblastic erythropoiesis OMIM
Sibling Menorrhagia OMIM
Sibling Methemoglobinemia (e.g. Hb M Boston 141800.0092) OMIM
Sibling Microangiopathic hemolytic anemia (Coomb negative) OMIM
Sibling Microangiopathic hemolytic anemia OMIM
Sibling Microcytic Anemia OMIM
Sibling Microcytic hypochromic anemia (disorder) OMIM
Sibling Microcytosis OMIM
Sibling Micromegakaryocytes (in some patients) OMIM
Sibling Mild alpha-granule deficiency OMIM
Sibling Mild Anemia OMIM
Sibling Mild bleeding episodes (epistaxis, GI bleeding, menorrhagia) OMIM
Sibling Mild form of hemoglobin H (Hb H) disease OMIM
Sibling Mild hypochromic microcytic anemia OMIM
Sibling Mild reticulocytosis in carrier females OMIM
Sibling Mild thrombocytopenia (before age 50) OMIM
Sibling Mild thrombocytopenia OMIM
Sibling Mild-moderate bleeding tendencies OMIM
Sibling Mild-moderate prolonged bleeding time OMIM
Sibling Mild-significant bleeding episodes (epistaxis, easy bruisability, postoperative hemorrhage, menorrhagia) OMIM
Sibling Mildly decreased to low-normal platelet count (80-150 x 10(9)/L) OMIM
Sibling Moderate-severe bleeding tendencies (epistaxis, menorrhagia, hemarthrosis, easy bruisability) OMIM
Sibling Monocytosis OMIM
Sibling Monosomy 7 of Bone Marrow OMIM
Sibling Mucocutaneous bleeding due to platelet dysfunction OMIM
Sibling Mucocutaneous bleeding OMIM
Sibling Multinuclear erythroblasts OMIM
Sibling Multinucleated erythroblasts OMIM
Sibling Myelodysplastic Syndrome OMIM
Sibling Myelofibrosis OMIM
Sibling Myeloid Leukemia, Chronic OMIM
Sibling Myelokathexis (retention of neutrophils in the bone marrow) OMIM
Sibling Myeloproliferative disease OMIM
Sibling Myelosuppression develops on standard doses of thiopurine drugs OMIM
Sibling MYH9-positive inclusions on immunohistochemical staining OMIM
Sibling Neonatal alloimmune thrombocytopenia (NAIT) OMIM
Sibling Neonatal hemolytic anemia (harderoporphyria) OMIM
Sibling Neutropenia (in some patients) OMIM
Sibling Neutropenia, chronic or cyclic OMIM
Sibling Neutropenia, mild OMIM
Sibling Neutropenia, severe congenital (in some patients) OMIM
Sibling Neutropenia, variable OMIM
Sibling Neutropenia OMIM
Sibling Neutrophil maturation in bone marrow intact OMIM
Sibling Neutrophil membranes show absence of sialyl-Lewis-X OMIM
Sibling Neutrophilia (finding) OMIM
Sibling No 'Swiss cheese' abnormality OMIM
Sibling No abnormality OMIM
Sibling No bone marrow abnormalities OMIM
Sibling No hemolysis OMIM
Sibling No hemophagocytosis OMIM
Sibling No increased bleeding tendency OMIM
Sibling No leukocyte inclusion bodies on Giemsa staining OMIM
Sibling No leukocyte inclusions on Giemsa staining OMIM
Sibling No neutrophil inclusions OMIM
Sibling No significant hemolysis OMIM
Sibling Nonclonal myeloproliferation OMIM
Sibling Normal beta-thromboglobulin OMIM
Sibling Normal hematologic parameters (both patients) OMIM
Sibling Normal heterochromatin in erythroblasts OMIM
Sibling Normal levels of known coagulation factors OMIM
Sibling Normal mean platelet volume (MPV) OMIM
Sibling Normal or increased platelet count OMIM
Sibling Normal oxygen affinity of hemoglobin OMIM
Sibling Normal peripheral red blood cell survival time OMIM
Sibling Normal platelet aggregation response to ristocetin and arachidonic acid (AA) OMIM
Sibling Normal platelet aggregation studies OMIM
Sibling Normal platelet fibrinogen OMIM
Sibling Normal platelet size (normal MPV) OMIM
Sibling Normal platelet size and morphology OMIM
Sibling Normal platelet size OMIM
Sibling Normal prothrombin and partial chromoplastin times OMIM
Sibling Normal red cell morphology OMIM
Sibling Normal red cell osmotic fragility OMIM
Sibling Normal serum thromboxane B2 OMIM
Sibling Normal spectrin membrane binding and binding sites (ankyrin) OMIM
Sibling Normal thrombospondin OMIM
Sibling Normal von Willebrand factor OMIM
Sibling Normochromic anemia OMIM
Sibling Normocytic anemia OMIM
Sibling Normocytic hypoplastic anemia OMIM
Sibling Normocytic pancytopenia following sulfa use OMIM
Sibling Nucleated peripheral red cells OMIM
Sibling Nucleated red cells in peripheral blood OMIM
Sibling Osmotic fragility (finding) OMIM
Sibling Oval macrocyte OMIM
Sibling Ovoid granulocyte nuclei (homozygote) OMIM
Sibling Pancytopenia (1 patient) OMIM
Sibling Pancytopenia (4 patients) OMIM
Sibling Pancytopenia (childhood) OMIM
Sibling Pancytopenia (in 2 of 3 siblings) OMIM
Sibling Pancytopenia (in 50% of patients) OMIM
Sibling Pancytopenia (in some patients) OMIM
Sibling Pancytopenia, episodic OMIM
Sibling Pancytopenia, mild OMIM
Sibling Pancytopenia OMIM
Sibling Pappenheimer body (morphologic abnormality) OMIM
Sibling Paroxysmal nocturnal hemoglobinuria OMIM
Sibling Partial thromboplastin time increased (finding) OMIM
Sibling Pathologic perinuclear mitochondrial iron deposits in erythrocyte precursors OMIM
Sibling Patients with type 2B develop thrombocytopenia OMIM
Sibling Peripheral blood smear shows abnormal red cells OMIM
Sibling Peripheral blood smear shows polychromasia OMIM
Sibling Pernicious anemia, not influenced by intrinsic factor OMIM
Sibling Pernicious Anemia OMIM
Sibling Persistence of fetal hemoglobin (5-30% HbF) OMIM
Sibling Persistence of fetal hemoglobin OMIM
Sibling Persistent or intermittent neutropenia OMIM
Sibling Petechiae OMIM
Sibling Philadelphia chromosome-positive acute lymphoblastic leukemia OMIM
Sibling Pigmented reticuloendothelial cells OMIM
Sibling Platelet aggregation abnormal OMIM
Sibling Platelet aggregation decreased OMIM
Sibling Platelet aggregation normal OMIM
Sibling Platelet anisocytosis OMIM
Sibling Platelet count normal OMIM
Sibling Platelet factor 4 decreased OMIM
Sibling Platelet function test normal OMIM
Sibling Platelet morphology normal OMIM
Sibling Platelets cannot synthesize thromboxane A2 from arachidonic acid OMIM
Sibling Platelets fail to inhibit the rise of cAMP levels in response to ADP OMIM
Sibling Platelets had abnormal membrane complexes OMIM
Sibling Platelets have decreased alpha-granules OMIM
Sibling Platelets have decreased expression of glycoprotein Ib-alpha (CD42B) OMIM
Sibling Platelets have decreased or absent alpha-granules OMIM
Sibling Platelets have increased expression of CD34 OMIM
Sibling Platelets have increased smooth endoplasmic reticulum OMIM
Sibling Platelets have paucity of granules OMIM
Sibling Platelets may show reduced ADP binding activity OMIM
Sibling Platelets show decreased GPIa/GPIIa surface complex OMIM
Sibling Platelets show decreased GPIb OMIM
Sibling Platelets show defective activation OMIM
Sibling Platelets show defective adhesion to collagen and subendothelium OMIM
Sibling Platelets show impaired aggregation in response to ADP OMIM
Sibling Platelets show normal ADP-induced shape change OMIM
Sibling Poikilocytosis OMIM
Sibling Polychromatophilic red cells OMIM
Sibling Polycythemia (e.g. Hb Chesapeake 141800.0018) OMIM
Sibling Polycythemia Neonatorum OMIM
Sibling Polycythemia OMIM
Sibling Post-surgical bleeding OMIM
Sibling Post-transfusion thrombocytopenia OMIM
Sibling Postsurgical bleeding OMIM
Sibling Presence of i erythrocyte antigen OMIM
Sibling Prolonged activated partial thromboplastin time (aPTT) OMIM
Sibling Prolonged APPT (in 1 patient) OMIM
Sibling Prolonged bleeding after surgery or trauma OMIM
Sibling Prolonged bleeding due to a qualitative defect in the VWF protein OMIM
Sibling Prolonged bleeding time (less common) OMIM
Sibling Prolonged bleeding time 15-to->30 minutes OMIM
Sibling Prolonged bleeding time due to quantitative decrease of VWF protein OMIM
Sibling Prolonged bleeding time OMIM
Sibling Prolonged bleeding OMIM
Sibling Promyelocytes have atypical nuclei and vacuolization of the cytoplasm OMIM
Sibling Prostaglandin-endoperoxide synthase 1 (PTGS1, 176805) deficiency in platelets OMIM
Sibling Protein C decreased OMIM
Sibling Protein C Deficiency Disease OMIM
Sibling Protein S decreased OMIM
Sibling Protein S Deficiency Disease OMIM
Sibling Prothrombin time increased OMIM
Sibling Pseudohyperkalemia Cardiff OMIM
Sibling Punctate red cells (in splenectomized patients) OMIM
Sibling Recurrent hemorrhagic events OMIM
Sibling Red blood cells lack H- antigen OMIM
Sibling Red blood cells may be microcytic or macrocytic OMIM
Sibling Red cell anisopoikilocytosis (in some patients) OMIM
Sibling Reduced hemopoiesis OMIM
Sibling Reduced leukocyte alkaline phosphatase OMIM
Sibling Reduced or absent erythroid precursors in bone marrow OMIM
Sibling Reduced platelet aggregation response to adenosine 5'-diphosphate (ADP) OMIM
Sibling Reduced stomatin at the erythrocyte membrane OMIM
Sibling Refractory anemias OMIM
Sibling Refractory macrocytic anemia OMIM
Sibling Reticulocyte count increased OMIM
Sibling Reticulocytopenia OMIM
Sibling Reticulocytosis (in some) OMIM
Sibling Reticulocytosis OMIM
Sibling Ringed sideroblasts on bone marrow aspirate OMIM
Sibling Ringed sideroblasts on bone marrow examination OMIM
Sibling Ringed sideroblasts on peripheral smear and bone marrow OMIM
Sibling Ringed sideroblasts seen on bone marrow aspirate ENDOCRINE : Type II diabetes mellitus OMIM
Sibling Schistocyte OMIM
Sibling Schistocytosis OMIM
Sibling Schizocytes OMIM
Sibling Sea-blue histiocyte (bone marrow) OMIM
Sibling Sea-blue histiocyte OMIM
Sibling Segmented neutrophils or band cells greater than 70% OMIM
Sibling Severe autoimmune cytopenia OMIM
Sibling Severe bleeding after biopsies (uncommon) OMIM
Sibling Severe congenital neutropenia OMIM
Sibling Severe hemolytic anemia OMIM
Sibling Severe thrombocytopenia (birth) OMIM
Sibling Severity of anemia can range from mild to life-threatening OMIM
Sibling Shortened red cell half-life OMIM
Sibling Sideroblastic anemia OMIM
Sibling Sky-blue leukocyte inclusion bodies (Dohle-like bodies) that contain clusters of ribosomes oriented along parallel microfilaments OMIM
Sibling Small and large vessel vasculitis OMIM
Sibling Small platelet size OMIM
Sibling Spherocytes OMIM
Sibling Spherocytosis Red cell membranes deficient in spectrin with band 1 reduced more than band 2 OMIM
Sibling Spherocytosis OMIM
Sibling Stomatocyte (cell) OMIM
Sibling Stomatocyte Count OMIM
Sibling Stomatocytes (may be few in number) OMIM
Sibling Stomatocytes (rare) OMIM
Sibling Stomatocytosis Result OMIM
Sibling Sustained eosinophilia (greater than 1,500/cubic mm) for greater than 6 months OMIM
Sibling Telomere Shortening OMIM
Sibling Thrombocytopenia (birth) OMIM
Sibling Thrombocytopenia (HELLP syndrome) OMIM
Sibling Thrombocytopenia (in some patients) OMIM
Sibling Thrombocytopenia (less common) OMIM
Sibling Thrombocytopenia (mean 42.7 x 10(9)/L) OMIM
Sibling Thrombocytopenia (onset birth-neonate, may be precipitated by cow's milk allergy) OMIM
Sibling Thrombocytopenia (rare) OMIM
Sibling Thrombocytopenia (reported in 1 patient) OMIM
Sibling Thrombocytopenia due to platelet alloimmunization OMIM
Sibling Thrombocytopenia post hemolytic anemia OMIM
Sibling Thrombocytopenia purpura (in some patients) OMIM
Sibling Thrombocytopenia, congenital (progresses to pancytopenia) OMIM
Sibling Thrombocytopenia, isolated (1 patient) OMIM
Sibling Thrombocytopenia, late-onset (1 patient) OMIM
Sibling Thrombocytopenia OMIM
Sibling Thrombocytosis (in some patients) OMIM
Sibling Thrombocytosis OMIM
Sibling Thromboembolism (25%) OMIM
Sibling Thromboembolism OMIM
Sibling Thrombosis OMIM
Sibling Thrombotic Microangiopathies OMIM
Sibling Thrombotic microangiopathy (hyaline thrombi of platelets and fibrin in terminal arterioles and capillaries) OMIM
Sibling Thromocytopenia (in some patients) OMIM
Sibling Total white blood cell count less than 25,000/cubic mm with 30-70% eosinophils OMIM
Sibling Transferrin saturation increased OMIM
Sibling Trilineage bone marrow failure OMIM
Sibling Trilineage dysplasia (in some patients) OMIM
Sibling Type I - methemoglobin concentration 10-35% OMIM
Sibling Unchanged passive permeability of sodium through red cell membrane at reduced temperatures OMIM
Sibling Unstable hemoglobin (e.g. Hb Contaldo 141800.0022) OMIM
Sibling Vacuolated lymphocytes (type II) OMIM
Sibling Vacuolated lymphocytes OMIM
Sibling Vacuolated macrophages OMIM
Sibling Vacuolated monocytes OMIM
Sibling Vacuolization in myeloid cell lines in the bone marrow OMIM
Sibling Vacuolization of marrow precursors OMIM
Sibling Variable bleeding episodes (menorrhagia, easy bruisability, postoperative hemorrhage) OMIM
Sibling Variable bleeding episodes OMIM
Sibling Variable bleeding tendencies OMIM
Sibling Variable platelet functional defects OMIM
Sibling Variable red blood cell size OMIM
Sibling Variable reductions in platelet aggregation OMIM
Sibling von Willebrand Disease OMIM
Sibling White blood cell abnormality OMIM
Sibling Acute Disease SNOMEDCT_US
Sibling AIDS-associated disorder SNOMEDCT_US
Sibling Anemia SNOMEDCT_US
Sibling Angioedema and/or urticaria SNOMEDCT_US
Sibling Autoimmune Diseases SNOMEDCT_US
Sibling Behcet Syndrome SNOMEDCT_US
Sibling Biphasic disease SNOMEDCT_US
Sibling Chronic disease SNOMEDCT_US
Sibling Chronic Fatigue Syndrome SNOMEDCT_US
Sibling Cicatrix SNOMEDCT_US
Sibling Communication impairment SNOMEDCT_US
Sibling Complications of Diabetes Mellitus SNOMEDCT_US
Sibling Complication SNOMEDCT_US
Sibling Congenital Disorders SNOMEDCT_US
Sibling Cyst SNOMEDCT_US
Sibling Degenerative Disorder SNOMEDCT_US
Sibling Developmental Disabilities SNOMEDCT_US
Sibling Disease due to Annelida SNOMEDCT_US
Sibling Disease due to Arthropod SNOMEDCT_US
Sibling Disease of presumed infectious origin SNOMEDCT_US
Sibling Disorder associated with menstruation AND/OR menopause SNOMEDCT_US
Sibling Disorder by body site SNOMEDCT_US
Sibling Disorder caused by synthetic cathinone SNOMEDCT_US
Sibling Disorder characterized by edema SNOMEDCT_US
Sibling Disorder characterized by fever SNOMEDCT_US
Sibling Disorder characterized by pain SNOMEDCT_US
Sibling Disorder due to medically assisted reproduction SNOMEDCT_US
Sibling Disorder of cellular component of blood SNOMEDCT_US
Sibling Disorder of fetus or newborn SNOMEDCT_US
Sibling Disorder of hematopoietic morphology SNOMEDCT_US
Sibling Disorder of immune function SNOMEDCT_US
Sibling Disorder of pregnancy SNOMEDCT_US
Sibling Disorder related to transplantation SNOMEDCT_US
Sibling Drug-related disorder SNOMEDCT_US
Sibling Effect of foreign body SNOMEDCT_US
Sibling Endometriosis SNOMEDCT_US
Sibling Endosalpingiosis SNOMEDCT_US
Sibling Endotoxicosis SNOMEDCT_US
Sibling Enterotoxemia SNOMEDCT_US
Sibling Environment related disease SNOMEDCT_US
Sibling Familial disease SNOMEDCT_US
Sibling Fibromatosis SNOMEDCT_US
Sibling Fibromyalgia SNOMEDCT_US
Sibling Foreign Bodies SNOMEDCT_US
Sibling Functional quadriplegia SNOMEDCT_US
Sibling Hematoma SNOMEDCT_US
Sibling Hereditary Diseases SNOMEDCT_US
Sibling Hyperproteinemia SNOMEDCT_US
Sibling Hypersensitivity condition SNOMEDCT_US
Sibling Hypertensive complication SNOMEDCT_US
Sibling Hyperviscosity syndrome SNOMEDCT_US
Sibling Idiopathic disease SNOMEDCT_US
Sibling Infectious Disorder SNOMEDCT_US
Sibling Inflammatory Disorder SNOMEDCT_US
Sibling Lipomatosis SNOMEDCT_US
Sibling Maltreatment syndromes SNOMEDCT_US
Sibling Maternal AND/OR fetal condition affecting labor AND/OR delivery SNOMEDCT_US
Sibling Mental disorders SNOMEDCT_US
Sibling Metabolic Disorder SNOMEDCT_US
Sibling Neoplasm and/or hamartoma SNOMEDCT_US
Sibling Non-labyrinthine vertigo SNOMEDCT_US
Sibling Nutrition Disorders SNOMEDCT_US
Sibling Nutritional deficiency associated condition SNOMEDCT_US
Sibling Obesity associated disorder SNOMEDCT_US
Sibling Obesity SNOMEDCT_US
Sibling Paraneoplastic Syndrome SNOMEDCT_US
Sibling pathologic fistula SNOMEDCT_US
Sibling Pigmentation Disorders SNOMEDCT_US
Sibling Poisoning SNOMEDCT_US
Sibling polyps SNOMEDCT_US
Sibling Post intensive care unit syndrome SNOMEDCT_US
Sibling Post vaccination fever SNOMEDCT_US
Sibling Post-infectious disorder SNOMEDCT_US
Sibling Propensity to adverse reactions SNOMEDCT_US
Sibling Proteus Syndrome SNOMEDCT_US
Sibling Puerperal Disorders SNOMEDCT_US
Sibling Radiation-induced disorder SNOMEDCT_US
Sibling Secondary and recurrent hemorrhage SNOMEDCT_US
Sibling Secondary hemorrhage SNOMEDCT_US
Sibling Self-induced disease SNOMEDCT_US
Sibling Sequela of disorder SNOMEDCT_US
Sibling Seroma SNOMEDCT_US
Sibling Sexual disorder SNOMEDCT_US
Sibling Sleep Disorders SNOMEDCT_US
Sibling Spontaneous hemorrhage SNOMEDCT_US
Sibling Subacute disease SNOMEDCT_US
Sibling Substance abuse problem SNOMEDCT_US
Sibling Traumatic AND/OR non-traumatic injury SNOMEDCT_US
Sibling Traumatic Hemorrhage SNOMEDCT_US
Sibling Ulcer SNOMEDCT_US
Sibling Vertiginous syndrome SNOMEDCT_US
Sibling Vomiting SNOMEDCT_US

Other Relationships:
Relationship Relationship Definitions Rel. Attribute Relationship Attr. Definitions Name Rel. Source Source List
Other Blood coagulation AOD
Other Vitamin K AOD
Other classified_as Coagulation and hemorrhagic disorders CCS_10
Other used_for Hereditary Factor VII Deficiency CSP
Other mapped_from Coagulation Factor Deficiency Syndrome CST
Other mapped_from Neonatal coagulation disorder CST
Other Abnormality of coagulation HPO
Other classifies Acute coagulopathy MDR
Other classifies Blood coagulation MDR
Other member_of Hemorrhage laboratory terms (SMQ) MDR
Other classifies Other coagulation defects MDR
Other classifies Postpartum coagulation defects, delivered, with mention of postpartum complication MDR
Other classifies Postpartum coagulation defects, unspecified as to episode of care or not applicable MDR
Other classifies Postpartum coagulation defects MDR
Other has_contraindicated_drug_MEDRT Acetophenazine maleate MED-RT
Other has_contraindicated_drug_MEDRT Acetophenazine MED-RT
Other has_contraindicated_drug_MEDRT ACETYLSALICYLATE SODIUM MED-RT
Other has_contraindicated_drug_MEDRT Aspirin MED-RT
Other has_contraindicated_drug_MEDRT BISMUTH HYDROXIDE MED-RT
Other has_contraindicated_drug_MEDRT Bismuth Subcarbonate MED-RT
Other has_contraindicated_drug_MEDRT bismuth subcitrate MED-RT
Other has_contraindicated_drug_MEDRT Bismuth Subgallate MED-RT
Other has_contraindicated_drug_MEDRT Bismuth Subnitrate MED-RT
Other has_contraindicated_drug_MEDRT Bismuth Subsalicylate MED-RT
Other has_contraindicated_drug_MEDRT BISMUTH-FORMIC-IODIDE MED-RT
Other has_contraindicated_drug_MEDRT Bismuth MED-RT
Other has_contraindicated_drug_MEDRT Clopidogrel Bisulfate MED-RT
Other has_contraindicated_drug_MEDRT Clopidogrel MED-RT
Other has_contraindicated_drug_MEDRT Dextran 1 MED-RT
Other has_contraindicated_drug_MEDRT Dextran 40 MED-RT
Other has_contraindicated_drug_MEDRT Dextran 70 MED-RT
Other has_contraindicated_drug_MEDRT Dextran 75 MED-RT
Other has_contraindicated_drug_MEDRT Dextran MED-RT
Other has_contraindicated_drug_MEDRT fluphenazine decanoate MED-RT
Other has_contraindicated_drug_MEDRT Fluphenazine enanthate MED-RT
Other has_contraindicated_drug_MEDRT Fluphenazine Hydrochloride MED-RT
Other has_contraindicated_drug_MEDRT Fluphenazine MED-RT
Other has_contraindicated_drug_MEDRT Garlic Oil MED-RT
Other has_contraindicated_drug_MEDRT Ginseng Preparation MED-RT
Other has_contraindicated_drug_MEDRT Hetastarch MED-RT
Other has_contraindicated_drug_MEDRT Methotrexate Sodium MED-RT
Other has_contraindicated_drug_MEDRT Methotrexate MED-RT
Other has_contraindicated_drug_MEDRT Mitomycin MED-RT
Other has_contraindicated_drug_MEDRT Oxaprozin MED-RT
Other has_contraindicated_drug_MEDRT Perphenazine MED-RT
Other has_contraindicated_drug_MEDRT Plicamycin MED-RT
Other has_contraindicated_drug_MEDRT Quetiapine fumarate MED-RT
Other has_contraindicated_drug_MEDRT quetiapine MED-RT
Other has_contraindicated_drug_MEDRT Thioridazine Hydrochloride MED-RT
Other has_contraindicated_drug_MEDRT Thioridazine MED-RT
Other has_contraindicated_drug_MEDRT Thiothixene hydrochloride MED-RT
Other has_contraindicated_drug_MEDRT Thiothixene MED-RT
Other has_contraindicated_drug_MEDRT Ticlopidine Hydrochloride MED-RT
Other has_contraindicated_drug_MEDRT Ticlopidine MED-RT
Other has_contraindicated_drug_MEDRT Trifluoperazine hydrochloride MED-RT
Other has_contraindicated_drug_MEDRT Trifluoperazine MED-RT
Other has_contraindicated_drug_MEDRT varicella-zoster immune globulin MED-RT
Other Bleeding tendency MEDLINEPLUS
Other Hemophilia, NOS MEDLINEPLUS
Other Aspects of mortality statistics MSH
Other chemically induced MSH
Other Complication Aspects MSH
Other Congenital MeSH qualifier MSH
Other diagnosis aspect MSH
Other diagnostic imaging aspects MSH
Other Economic MSH
Other embryologic MSH
Other enzymology MSH
Other epidemiologic MSH
Other ethnologic MSH
Other Etiology aspects MSH
Other genetic aspects MSH
Other Historical aspects qualifier MSH
Other immunology aspects MSH
Other In Blood MSH
Other In Cerebrospinal Fluid MSH
Other In Urine MSH
Other metabolic aspects MSH
Other Microbiological MSH
Other nursing therapy MSH
Other nutritional management MSH
Other parasitology MSH
Other Pathological aspects MSH
Other pharmacotherapeutic MSH
Other physiopathological MSH
Other prevention & control MSH
Other psychology qualifier MSH
Other radiotherapeutic MSH
Other Rehabilitation aspects MSH
Other Surgical aspects MSH
Other Taxonomic MSH
Other therapeutic aspects MSH
Other veterinary aspects MSH
Other viruses MSH
Other Other coagulation defects MTHICD9
Other Abnormal coagulation profile MTH
Other Blood Coagulation Factor MTH
Other Blood coagulation tests MTH
Other Blood coagulation MTH
Other Dacarbazine MTH
Other fibrinogen Petoskey MTH
Other Hemorrhagic Disorders MTH
Other Hemostasis procedure MTH
Other Thrombus MTH
Other Vitamin K MTH
Other Bleeding tendency NCIMTH
Other Coagulation process NCIMTH
Other May_Be_Associated_Disease_Of_Disease Aggressive natural killer-cell leukemia NCI
Other Parent_Is_NICHD Antithrombin III Deficiency NCI
Other Parent_Is_NICHD Bleeding tendency NCI
Other Has_NICHD_Parent Cardiovascular Diseases NCI
Other Parent_Is_NICHD Coagulation Factor Deficiency Syndrome NCI
Other Parent_Is_NICHD Congenital Bleeding Disorder NCI
Other Parent_Is_NICHD Consumptive Coagulopathy NCI
Other Parent_Is_CDRH Disseminated Intravascular Coagulation NCI
Other Parent_Is_NICHD Disseminated Intravascular Coagulation NCI
Other Parent_Is_NICHD Dysfibrinogenemia NCI
Other Concept_In_Subset FDA Center For Devices and Radiological Health Terminology NCI
Other Concept_In_Subset FDA Patient Problem Code Hierarchy NCI
Other Has_CDRH_Parent FDA Patient Problem Code Hierarchy NCI
Other May_Be_Associated_Disease_Of_Disease Heavy Chain Deposition Disease NCI
Other Has_NICHD_Parent Hematological Disease NCI
Other Disease_Has_Associated_Anatomic_Site Hematopoietic and Lymphatic System NCI
Other Disease_Has_Primary_Anatomic_Site Hematopoietic and Lymphatic System NCI
Other Disease_Has_Normal_Cell_Origin Hematopoietic and Lymphoid Cell NCI
Other Disease_Has_Normal_Tissue_Origin Hematopoietic and Lymphoid Tissue NCI
Other Parent_Is_NICHD High molecular weight kininogen deficiency NCI
Other Parent_Is_NICHD Immune-Mediated Coagulopathy NCI
Other May_Be_Associated_Disease_Of_Disease Light Chain Deposition Disease NCI
Other Concept_In_Subset Neonatal Research Network Terminology NCI
Other Concept_In_Subset Pediatric Adverse Events Terminology NCI
Other Concept_In_Subset Pediatric Hematology-Oncology Terminology NCI
Other Concept_In_Subset Pediatric Terminology NCI
Other Parent_Is_NICHD Plasma Kallikrein Deficiency NCI
Other Parent_Is_NICHD Thrombophilia NCI
Other Parent_Is_NICHD Thrombotic Microangiopathies NCI
Other Parent_Is_NICHD Tissue Kallikrein Deficiency NCI
Other Parent_Is_NICHD von Willebrand Disease NCI
Other has_contraindicated_drug 0.15 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.2 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.25 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.3 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.35 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.4 ML Methotrexate 18.8 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.4 ML Methotrexate 25 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.4 ML Methotrexate 37.5 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.4 ML Methotrexate 43.8 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.4 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.4 ML Methotrexate 56.3 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.4 ML Methotrexate 62.5 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.45 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.5 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.55 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 0.6 ML Methotrexate 50 MG/ML Auto-Injector NDFRT
Other has_contraindicated_drug 10 ML Methotrexate 25 MG/ML Injection NDFRT
Other has_contraindicated_drug 2 ML Methotrexate 25 MG/ML Injection NDFRT
Other has_contraindicated_drug 24 HR Aspirin 162.5 MG Extended Release Oral Capsule NDFRT
Other has_contraindicated_drug 24 HR quetiapine 150 MG Extended Release Oral Tablet NDFRT
Other has_contraindicated_drug 24 HR quetiapine 50 MG Extended Release Oral Tablet NDFRT
Other has_contraindicated_drug 4 ML Methotrexate 25 MG/ML Injection NDFRT
Other has_contraindicated_drug 8 ML Methotrexate 25 MG/ML Injection NDFRT
Other has_contraindicated_drug acetophenazine 20 MG Oral Tablet NDFRT
Other has_contraindicated_drug Acetophenazine maleate NDFRT
Other has_contraindicated_drug Acetophenazine NDFRT
Other has_contraindicated_drug ACETYLSALICYLATE SODIUM NDFRT
Other has_contraindicated_drug Aspirin 120 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 125 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 130 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 162 MG Delayed Release Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 165 MG Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 165mg e/c tablet NDFRT
Other has_contraindicated_drug Aspirin 195 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 200 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 227.5mg gum tablet NDFRT
Other has_contraindicated_drug Aspirin 300 MG Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 300mg suppository NDFRT
Other has_contraindicated_drug Aspirin 325 MG Delayed Release Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 325 MG Oral Capsule NDFRT
Other has_contraindicated_drug Aspirin 325 MG Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 325 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 486 MG Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 488 MG Delayed Release Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 500 MG Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 500mg e/c tablet NDFRT
Other has_contraindicated_drug Aspirin 60 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 600mg suppository NDFRT
Other has_contraindicated_drug Aspirin 65 MG Chewable Tablet NDFRT
Other has_contraindicated_drug Aspirin 65 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 650 MG Oral Powder NDFRT
Other has_contraindicated_drug Aspirin 650 MG Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 650 MG Rectal Suppository NDFRT
Other has_contraindicated_drug Aspirin 650mg e/c tablet NDFRT
Other has_contraindicated_drug Aspirin 650mg m/r tablet NDFRT
Other has_contraindicated_drug Aspirin 75 MG Chewable Tablet NDFRT
Other has_contraindicated_drug Aspirin 800 MG Extended Release Oral Capsule NDFRT
Other has_contraindicated_drug Aspirin 800 MG Extended Release Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 81 MG Chewable Tablet NDFRT
Other has_contraindicated_drug Aspirin 81 MG Delayed Release Oral Tablet NDFRT
Other has_contraindicated_drug Aspirin 850 MG Oral Powder NDFRT
Other has_contraindicated_drug Aspirin 975mg e/c tablet NDFRT
Other has_contraindicated_drug Aspirin 975mg m/r tablet NDFRT
Other has_contraindicated_drug ASPIRIN PWDR NDFRT
Other has_contraindicated_drug Aspirin NDFRT
Other has_contraindicated_drug BISMUTH HYDROXIDE NDFRT
Other has_contraindicated_drug BISMUTH RESORCIN COMPOUND NDFRT
Other has_contraindicated_drug BISMUTH SUBCARBONATE PWDR NDFRT
Other has_contraindicated_drug Bismuth Subcarbonate NDFRT
Other has_contraindicated_drug bismuth subcitrate NDFRT
Other has_contraindicated_drug bismuth subgallate 200 MG Chewable Tablet NDFRT
Other has_contraindicated_drug bismuth subgallate 400 MG Chewable Tablet NDFRT
Other has_contraindicated_drug Bismuth Subgallate NDFRT
Other has_contraindicated_drug BISMUTH SUBIODIDE NDFRT
Other has_contraindicated_drug BISMUTH SUBNITRATE PWDR NDFRT
Other has_contraindicated_drug Bismuth Subnitrate NDFRT
Other has_contraindicated_drug bismuth subsalicylate 17.5 MG/ML Oral Suspension NDFRT
Other has_contraindicated_drug bismuth subsalicylate 262 MG Chewable Tablet NDFRT
Other has_contraindicated_drug bismuth subsalicylate 262 MG Oral Tablet NDFRT
Other has_contraindicated_drug bismuth subsalicylate 300 MG Oral Tablet NDFRT
Other has_contraindicated_drug bismuth subsalicylate 35 MG/ML Oral Suspension NDFRT
Other has_contraindicated_drug Bismuth Subsalicylate NDFRT
Other has_contraindicated_drug BISMUTH-FORMIC-IODIDE NDFRT
Other has_contraindicated_drug Bismuth NDFRT
Other has_contraindicated_drug Clopidogrel 300 mg oral tablet NDFRT
Other has_contraindicated_drug Clopidogrel 75 mg oral tablet NDFRT
Other has_contraindicated_drug Clopidogrel Bisulfate NDFRT
Other has_contraindicated_drug Clopidogrel NDFRT
Other has_contraindicated_drug Dextran 1 150mg/mL injection solution ampule NDFRT
Other has_contraindicated_drug Dextran 1 NDFRT
Other has_contraindicated_drug Dextran 40 NDFRT
Other has_contraindicated_drug Dextran 70 320 MG/ML Injectable Solution NDFRT
Other has_contraindicated_drug Dextran 70 NDFRT
Other has_contraindicated_drug Dextran 75 60 MG/ML Injectable Solution NDFRT
Other has_contraindicated_drug Dextran 75 NDFRT
Other has_contraindicated_drug Dextran NDFRT
Other has_contraindicated_drug fluphenazine decanoate 25 MG/ML Injectable Solution NDFRT
Other has_contraindicated_drug Fluphenazine decanoate 25mg/mL injection solution 1mL prefilled syringe NDFRT
Other has_contraindicated_drug fluphenazine decanoate NDFRT
Other has_contraindicated_drug Fluphenazine enanthate 25 MG/ML Injectable Solution NDFRT
Other has_contraindicated_drug Fluphenazine enanthate NDFRT
Other has_contraindicated_drug Fluphenazine Hydrochloride 0.5 MG/ML Oral Solution NDFRT
Other has_contraindicated_drug Fluphenazine Hydrochloride 1 MG Extended Release Oral Tablet NDFRT
Other has_contraindicated_drug Fluphenazine hydrochloride 1 mg oral tablet NDFRT
Other has_contraindicated_drug Fluphenazine hydrochloride 10 mg oral tablet NDFRT
Other has_contraindicated_drug Fluphenazine Hydrochloride 2.5 MG Delayed Release Oral Tablet NDFRT
Other has_contraindicated_drug Fluphenazine hydrochloride 2.5 mg oral tablet NDFRT
Other has_contraindicated_drug Fluphenazine Hydrochloride 2.5 MG/ML Injectable Solution NDFRT
Other has_contraindicated_drug Fluphenazine hydrochloride 5 mg oral tablet NDFRT
Other has_contraindicated_drug Fluphenazine hydrochloride 5mg/mL liquid NDFRT
Other has_contraindicated_drug Fluphenazine Hydrochloride NDFRT
Other has_contraindicated_drug Fluphenazine NDFRT
Other has_contraindicated_drug GARLIC OIL CAP NDFRT
Other has_contraindicated_drug GARLIC OIL TAB,EC NDFRT
Other has_contraindicated_drug Garlic Oil NDFRT
Other has_contraindicated_drug GINSENG CAP/TAB NDFRT
Other has_contraindicated_drug Ginseng Preparation NDFRT
Other has_contraindicated_drug Hetastarch 6% infusion solution bottle NDFRT
Other has_contraindicated_drug Hetastarch NDFRT
Other has_contraindicated_drug Methotrexate 10 mg oral tablet NDFRT
Other has_contraindicated_drug Methotrexate 1000 MG Injection NDFRT
Other has_contraindicated_drug Methotrexate 12.5mg/mL infusion solution 30mL vial NDFRT
Other has_contraindicated_drug Methotrexate 15 MG Oral Tablet NDFRT
Other has_contraindicated_drug Methotrexate 2.5 mg oral tablet NDFRT
Other has_contraindicated_drug Methotrexate 2.5mg/mL injection solution 2mL vial NDFRT
Other has_contraindicated_drug Methotrexate 25 MG/ML Injection NDFRT
Other has_contraindicated_drug Methotrexate 5 mg oral tablet NDFRT
Other has_contraindicated_drug Methotrexate 7.5 mg oral tablet NDFRT
Other has_contraindicated_drug METHOTREXATE NA 2.5MG TAB DOSE PACK,8 NDFRT
Other has_contraindicated_drug METHOTREXATE NA 20MG/VIL INJ NDFRT
Other has_contraindicated_drug Methotrexate Sodium NDFRT
Other has_contraindicated_drug Methotrexate NDFRT
Other has_contraindicated_drug Mitomycin 0.2 MG/ML Ophthalmic Solution NDFRT
Other has_contraindicated_drug MITOMYCIN 0.5MG/ML INJ NDFRT
Other has_contraindicated_drug Mitomycin 10mg powder for injection solution vial NDFRT
Other has_contraindicated_drug Mitomycin 40 MG Injection NDFRT
Other has_contraindicated_drug Mitomycin 5 MG Injection NDFRT
Other has_contraindicated_drug Mitomycin NDFRT
Other has_contraindicated_drug oxaprozin 600 MG Oral Tablet NDFRT
Other has_contraindicated_drug Oxaprozin NDFRT
Other has_contraindicated_drug Perphenazine 16 mg oral tablet NDFRT
Other has_contraindicated_drug Perphenazine 16mg/5ml oral concentrate NDFRT
Other has_contraindicated_drug Perphenazine 2 MG Extended Release Oral Tablet NDFRT
Other has_contraindicated_drug Perphenazine 2 mg oral tablet NDFRT
Other has_contraindicated_drug Perphenazine 4 MG Extended Release Oral Tablet NDFRT
Other has_contraindicated_drug Perphenazine 4 mg oral tablet NDFRT
Other has_contraindicated_drug Perphenazine 5mg/mL injection solution 1mL vial NDFRT
Other has_contraindicated_drug Perphenazine 8 MG Extended Release Oral Tablet NDFRT
Other has_contraindicated_drug Perphenazine 8 mg oral tablet NDFRT
Other has_contraindicated_drug Perphenazine NDFRT
Other has_contraindicated_drug Plicamycin 2.5g powder for injection solution vial NDFRT
Other has_contraindicated_drug Plicamycin NDFRT
Other has_contraindicated_drug Quetiapine 100 mg oral tablet NDFRT
Other has_contraindicated_drug Quetiapine 200 mg oral tablet NDFRT
Other has_contraindicated_drug Quetiapine 200mg extended release tablet NDFRT
Other has_contraindicated_drug Quetiapine 25 mg oral tablet NDFRT
Other has_contraindicated_drug Quetiapine 300 mg oral tablet NDFRT
Other has_contraindicated_drug Quetiapine 300mg extended release tablet NDFRT
Other has_contraindicated_drug Quetiapine 400 mg oral tablet NDFRT
Other has_contraindicated_drug Quetiapine 400mg extended release tablet NDFRT
Other has_contraindicated_drug Quetiapine 50 mg oral tablet NDFRT
Other has_contraindicated_drug QUETIAPINE FUMARATE STARTER PACK NDFRT
Other has_contraindicated_drug Quetiapine fumarate NDFRT
Other has_contraindicated_drug quetiapine NDFRT
Other has_contraindicated_drug Thioridazine 10 MG Delayed Release Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 10 MG Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 100 MG Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 100mg/5mL oral suspension NDFRT
Other has_contraindicated_drug Thioridazine 100mg/mL oral concentrate NDFRT
Other has_contraindicated_drug Thioridazine 15 MG Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 150 MG Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 200 MG Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 25 MG Delayed Release Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 25mg/5mL oral suspension NDFRT
Other has_contraindicated_drug Thioridazine 50 MG Delayed Release Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 50 MG Oral Tablet NDFRT
Other has_contraindicated_drug Thioridazine 50mg/5mL s/f oral solution NDFRT
Other has_contraindicated_drug Thioridazine hydrochloride 25 mg oral tablet NDFRT
Other has_contraindicated_drug Thioridazine hydrochloride 30mg/ml oral concentrate NDFRT
Other has_contraindicated_drug Thioridazine Hydrochloride NDFRT
Other has_contraindicated_drug Thioridazine NDFRT
Other has_contraindicated_drug Thiothixene 1 MG Oral Capsule NDFRT
Other has_contraindicated_drug Thiothixene 10 MG Oral Capsule NDFRT
Other has_contraindicated_drug Thiothixene 2 MG Oral Capsule NDFRT
Other has_contraindicated_drug Thiothixene 2 MG/ML Injectable Solution NDFRT
Other has_contraindicated_drug Thiothixene 20 MG Oral Capsule NDFRT
Other has_contraindicated_drug Thiothixene 5 MG Oral Capsule NDFRT
Other has_contraindicated_drug Thiothixene 5 MG/ML Injectable Solution NDFRT
Other has_contraindicated_drug Thiothixene hydrochloride 5mg/mL oral solution NDFRT
Other has_contraindicated_drug Thiothixene hydrochloride NDFRT
Other has_contraindicated_drug Thiothixene NDFRT
Other has_contraindicated_drug Ticlopidine hydrochloride 250 mg oral tablet NDFRT
Other has_contraindicated_drug Ticlopidine Hydrochloride NDFRT
Other has_contraindicated_drug Ticlopidine NDFRT
Other may_be_treated_by Tranexamic acid 100mg/mL intravenous solution 10mL vial NDFRT
Other may_be_treated_by Tranexamic acid 500 mg oral tablet NDFRT
Other may_be_treated_by Tranexamic acid 650 mg oral tablet NDFRT
Other may_be_treated_by TRANEXAMIC ACID PWDR NDFRT
Other may_be_treated_by Tranexamic Acid NDFRT
Other has_contraindicated_drug Trifluoperazine 1 MG Extended Release Oral Tablet NDFRT
Other has_contraindicated_drug Trifluoperazine 1 mg oral tablet NDFRT
Other has_contraindicated_drug Trifluoperazine 10 MG Oral Tablet NDFRT
Other has_contraindicated_drug Trifluoperazine 2 MG Oral Tablet NDFRT
Other has_contraindicated_drug Trifluoperazine 5 mg oral tablet NDFRT
Other has_contraindicated_drug Trifluoperazine hydrochloride 10mg/mL solution NDFRT
Other has_contraindicated_drug Trifluoperazine hydrochloride 2mg/mL injection solution 10mL vial NDFRT
Other has_contraindicated_drug Trifluoperazine hydrochloride NDFRT
Other has_contraindicated_drug Trifluoperazine NDFRT
Other has_contraindicated_drug Varicella-zoster immune globulin 125 iu powder for injection solution vial NDFRT
Other has_contraindicated_drug varicella-zoster immune globulin NDFRT
Other has_contraindicated_drug Varicella-zoster immunoglobulin 250mg powder for injection solution vial NDFRT
Other has_contraindicated_drug {12 (Methotrexate 2.5 MG Oral Tablet) } Pack NDFRT
Other has_contraindicated_drug {16 (Methotrexate 2.5 MG Oral Tablet) } Pack NDFRT
Other has_contraindicated_drug {20 (Methotrexate 2.5 MG Oral Tablet) } Pack NDFRT
Other manifestation_of Coloboma, Ocular, And Ichthyosis, Brain Malformations, And Endocrine Abnormalities OMIM
Other manifestation_of INFANTILE LIVER FAILURE SYNDROME 1 OMIM
Other manifestation_of Malignant hyperpyrexia due to anesthesia OMIM
Other manifestation_of NOONAN SYNDROME 9 OMIM
Other manifestation_of Periventricular Heterotopia, X-Linked OMIM
Other associated_with Antepartum hemorrhage associated with coagulation defect SNOMEDCT_US
Other associated_with Antepartum hemorrhage with coagulation defect - delivered SNOMEDCT_US
Other associated_with Antepartum hemorrhage with coagulation defect - not delivered SNOMEDCT_US
Other cause_of Arthritis due to bleeding disorder SNOMEDCT_US
Other focus_of Clot retraction, screen SNOMEDCT_US
Other focus_of Documentation of anticoagulation medication action plan SNOMEDCT_US
Other associated_finding_of Family history of blood coagulation disorder SNOMEDCT_US
Other associated_finding_of H/O: coagulation defect SNOMEDCT_US
Other associated_with Intrapartum hemorrhage with coagulation defect SNOMEDCT_US
Other cause_of Purpura of skin and or skin-associated mucous membrane co-occurrent and due to coagulation disorder SNOMEDCT_US

'Blood Coagulation Disorders' By Source: NCI
Select source:   NCI  AOD   COSTAR   CSP   CST   DXP   FDA   HPO   ICD10   ICD10CM   ICD9CM   MDR   MEDLINEPLUS   MSH   MTH   MTHICD9   NDFRT   NICHD   OMIM   SNOMEDCT_US  

Synonyms
Term Source Source List Type Term Type Definition Code
Coagulation Disorder NCI PT C2902


Relationships
Relationship Relationship Definitions Rel. Attribute Relationship Attr. Definitions CUI Term Source Source List Type Term Type Definition Code
Parent isa C1518374 Non-Neoplastic Hematologic and Lymphocytic Disorder NCI PT C26324
Child inverse_isa C0272375 Antithrombin III Deficiency NCI PT C98815
Child inverse_isa C1458140 Bleeding Diathesis NCI PT C115221
Child inverse_isa C0272271 Coagulation Disorder Related to Liver Dysfunction NCI PT C101333
Child inverse_isa C0272315 Coagulation Factor Deficiency NCI PT C27215
Child inverse_isa C3641106 Congenital Bleeding Disorder NCI PT C103172
Child inverse_isa CL514278 Consumptive Coagulopathy NCI PT C131658
Child inverse_isa C0012739 Disseminated Intravascular Coagulation NCI PT C2992
Child inverse_isa C1260903 Dysfibrinogenemia NCI PT C131659
Child inverse_isa C0019061 Hemolytic Uremic Syndrome NCI PT C75545
Child inverse_isa C0272340 High Molecular Weight Kininogen Deficiency NCI PT C98946
Child inverse_isa C0919890 Hyperfibrinogenemia NCI PT C113740
Child inverse_isa CL514666 Immune-Mediated Coagulopathy NCI PT C131673
Child inverse_isa CL514322 Plasma Kallikrein Deficiency NCI PT C131648
Child inverse_isa C2750067 Plasminogen Activator Inhibitor-1 Deficiency NCI PT C133884
Child inverse_isa C0398623 Thrombophilia NCI PT C84479
Child inverse_isa C2717961 Thrombotic Microangiopathy NCI PT C62605
Child inverse_isa CL514344 Tissue Kallikrein Deficiency NCI PT C131651
Child inverse_isa C0042974 von Willebrand Disease NCI PT C68677
Other Concept_In_Subset C1880652 FDA Center For Devices and Radiological Health Terminology NCI PT C62596
Other Concept_In_Subset C1709489 FDA Patient Problem Code Hierarchy NCI PT C54450
Other Concept_In_Subset C3274563 Neonatal Research Network Terminology NCI PT C99147
Other Concept_In_Subset C3897974 Pediatric Adverse Events Terminology NCI PT C118464
Other Concept_In_Subset CL520485 Pediatric Hematology-Oncology Terminology NCI PT C132009
Other Concept_In_Subset C2983498 Pediatric Terminology NCI PT C90259
Other Disease_Has_Associated_Anatomic_Site C1512394 Hematopoietic and Lymphatic System NCI PT C41165
Other Disease_Has_Normal_Cell_Origin C1512385 Hematopoietic and Lymphoid Cell NCI PT C32725
Other Disease_Has_Normal_Tissue_Origin C1512398 Hematopoietic and Lymphoid Tissue NCI PT C41168
Other Has_NICHD_Parent C0007222 Cardiovascular Disorder NCI PT C2931
Other Has_NICHD_Parent C0018939 Hematologic and Lymphocytic Disorder NCI PT C26323
Other May_Be_Associated_Disease_Of_Disease C1292777 Aggressive NK-Cell Leukemia NCI PT C8647
Other May_Be_Associated_Disease_Of_Disease C1333947 Heavy Chain Deposition Disease NCI PT C7339
Other May_Be_Associated_Disease_Of_Disease C0238239 Light Chain Deposition Disease NCI PT C7727
Other Parent_Is_CDRH C0012739 Disseminated Intravascular Coagulation NCI PT C2992
Other Parent_Is_NICHD C0272375 Antithrombin III Deficiency NCI PT C98815
Other Parent_Is_NICHD C1458140 Bleeding Diathesis NCI PT C115221
Other Parent_Is_NICHD C0272315 Coagulation Factor Deficiency NCI PT C27215
Other Parent_Is_NICHD C3641106 Congenital Bleeding Disorder NCI PT C103172
Other Parent_Is_NICHD CL514278 Consumptive Coagulopathy NCI PT C131658
Other Parent_Is_NICHD C1260903 Dysfibrinogenemia NCI PT C131659
Other Parent_Is_NICHD C0272340 High Molecular Weight Kininogen Deficiency NCI PT C98946
Other Parent_Is_NICHD CL514666 Immune-Mediated Coagulopathy NCI PT C131673
Other Parent_Is_NICHD CL514322 Plasma Kallikrein Deficiency NCI PT C131648
Other Parent_Is_NICHD C0398623 Thrombophilia NCI PT C84479
Other Parent_Is_NICHD C2717961 Thrombotic Microangiopathy NCI PT C62605
Other Parent_Is_NICHD CL514344 Tissue Kallikrein Deficiency NCI PT C131651
Other Parent_Is_NICHD C0042974 von Willebrand Disease NCI PT C68677

Mainbox Bottom